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 The emergence of complex behavioral, sensory, and cognitive capacities in 
bilaterian animals was enabled by the evolution of diverse ensembles of neuronal cell-
types. To understand how discrete populations of neurons participate in complex circuit-
level processes, contemporary systems-level approaches have sought to assign cell-
type-specific transcriptional features to define heterogeneous populations across the 
brain. However, gene expression is inherently plastic, and how discrete neuronal cell-
types are sculpted by systemic pressures is not well understood. Here, we leverage 
high-throughput single-cell RNA-sequencing to explore how chronic pressures are 
represented across discrete neural systems in brain regions that are involved in the 
homeostatic responses to these pressures. We study this concept of transcriptional 
allostasis through two different models. First, we examine how lateral hypothalamic area 
neurons are shaped by chronic high fat diet in obesity. Next, we investigate the kinetics 
of cell-type-specific alterations in transcriptional states within the nucleus accumbens 
and medial thalamic complex during spontaneous withdrawal from escalating morphine. 
With this, we identify and characterize discrete substrates that are uniquely sensitive to 
biologically-relevant allostatic pressures, thereby potentially contributing to the 
development of associated maladaptive states in these systems. 
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CHAPTER 1. GENERAL INTRODUCTION: 
THE HETEROGENEITY OF NEURAL TISSUES 
On the emergence of neural diversity 
Living structures—from unicellular protists to complex chordates—can be defined 
by their unique capacity to resist thermodynamic entropic forces and maintain 
sophisticated, enduring forms1. Essential to this is the ability of living biological systems 
to sample physical signals, both intrinsic and extrinsic, and generate an appropriate 
response that contributes to their structural and temporal persistence. In the most 
fundamental biological unit of life—the cell—such abilities are achieved through 
extracellular and intracellular receptor systems coupled to signaling relays, which 
ultimately actuate a conditionally-specific reaction. In multicellular organisms, however, 
maintaining complex forms requires signals to be communicated not only within the cell 
but also between cells, sometimes across distant regions and between dissimilar 
tissues. The capacity to faithfully communicate detailed information across distances is 
therefore not only an adaptation, but an absolute requisite for complex multicellularity. 
Although it is unclear whether multicellularity began through symbiosis, cellularization of 
a syncytium, or through colonial organization, survival under all three hypotheses is 
dependent on the ability of individual cells to exchange information about local internal 
and external states (Brunet and King, 2017). In its most rudimentary forms, such
                                               
1 Ludwig Boltzmann proposed a thermodynamic theory of life in 1875, summarized: “The general struggle for 
existence of animate beings is not a struggle for raw materials…nor for energy which exist in plenty…but a struggle 
for entropy, which becomes available through the transition of energy from the hot sun to the cold earth.” 
 2 
communication occurs primarily through juxtacrine and paracrine mechanisms, with air 
or water serving as the carrier medium for volatile or soluble chemical cues. However, 
juxtacrine communication requires contact, and paracrine diffusion-based 
communication is generally slow, imprecise, and subject to temporal averaging and a 
loss in amplitude with distance (Berg and Purcell, 1977; Gregor et al., 2007; Shalek et 
al., 2014). Consequently, as biological systems evolved to occupy more specialized 
ecological niches, so too did their need for rapid, high-fidelity transmission of complex 
signals across larger distances. 
 Although all cells maintain specific intracellular ionic concentrations and 
therefore an electrical membrane potential, elementary examples of rapid electrical 
conduction between spatially-distant cells has been observed in some basal metazoans 
including certain classes of colonial hydrozoans and Porifera. For example, ancient 
glass sponges conduct electrical impulses through a trabecular syncytium to precisely 
coordinate ciliary currents required for feeding (Leys and Mackie, 1997; Leys et al., 
1999). However, such electrical conduction is limited in its speed of transmission and its 
potential signal complexity, and although sponges are relatively homogenous in cell-
type, such communication would be unable to act on distinct receptor or effector tissues 
outside of the syncytium. Still, the use of electrical conduction is thought to allow these 
species to occupy unique ecological niches by providing them the ability to rapidly 
toggle filter feeding to protect them from transient environmental hazards (an example 
of behavioral instinct). As such, these species represent the longest-living known 
metazoan classes, with lifespan estimates in some glass sponges reaching tens-of-
thousands of years (Gatti, 2001; Jochum et al., 2012). 
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As are many things in comparative evolutionary taxonomy, the ancestral origins 
of the prototypical neuron remain in dispute. The earliest two hypotheses, both 
generated by students of Ernst Haeckel, proposed competing monophyletic versus 
polyphyletic theories for neural origins (Hertwig and Hertwig, 1878; Kleinenberg, 1872; 
Moroz, 2009). Although the early events in nervous system evolution are unclear, and 
there is significant evidence supporting both a single common ancestor for all neural 
components as well as the merging of separate anatomical and genetic components 
from distinct ancestral lineages, contemporary theories mostly agree that neurons 
eventually evolved from specialized cells of epithelial origin (Kristan, 2016). The most 
primitive living example of a complete prototypical neural circuit is found in the true 
jellyfish (Scyphozoa), where specialized epithelially-derived photo- and proprioceptive 
sensory structures act on pacemaker neurons that chemically synapse with motor 
structures to coordinate rhythmic movement (Katsuki and Greenspan, 2013). 
The emergence of simple sensory input-to-motor output circuits is thought to 
have authorized an evolutionary scramble that promoted the rapid selective 
specialization of cell-types, ultimately yielding a heterogeneous array of sensory 
neurons, interneurons, and projection neurons that allowed metazoa to successfully 
occupy more specialized ecological niches through the accumulation of diverse 
sensory, behavioral—and eventually—cognitive capacities (Kristan, 2016; Monk and 
Paulin, 2014). Over roughly 500 million years, this selective specialization of neural 
systems has fashioned a stunning organization of cell-types in the brain of unmatched 
functional, structural, and molecular complexity. 
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Historical Approaches to Cataloging the Brain 
 The concept of neuronal “cell-types” was first acknowledged and studied by 
Santiago Ramón y Cajal, who—by using a what was then state-of-the art silver staining 
method developed by Camillo Golgi—was able to visualize sparse groups of neurons 
within densely populated regions with clear morphological detail (Santiago Ramón y 
Cajal, 1909). With this, he established that neurons were discrete units rather than an 
interconnected mesh, and that a wide catalog of neuronal morphologies existed 
throughout the nervous system. The categorization of cell-types by morphological 
features continued with the development of more sophisticated imaging and staining 
techniques (MacNeil and Masland, 1998), and these metrics were combined with 
classifications according to connectivity across brain regions (Shepherd, 2004). 
Additionally, the invention of single- and multi-cell electrophysiological recording 
methods allowed for neurons to be classified by inherent electrical properties and firing 
patterns, and these electrophysiological characterizations were subsequently combined 
with morphological and connectivity information to more-precisely classify cells in the 
brain (Ascoli et al., 2008; Devries and Baylor, 1997; Gupta et al., 2000; Jiang, 2015; 
Káradóttir and Attwell, 2006; Somogyi and Klausberger, 2005). 
 In addition to morphological and physiological information, an appreciation for the 
molecular heterogeneity of neuronal populations began with the recognition of distinct 
enzymes, receptors, and neuropeptides involved in neuronal functional specification 
(Fremeau et al., 2001; Lightman, 1988; Shirasaki and Pfaff, 2002). With the 
development of in situ hybridization methods, testing for the expression of specific 
genes was no longer dependent on raising antibodies against purified antigens, instead 
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allowing for the detection any known transcript coding sequence to be readily examined 
(Lewis et al., 1988; Sunkin et al., 2012). Concurrently, more advanced high-dimensional 
methods for characterizing the transcriptional features of neuronal cells enabled the 
enormous magnitude of neuronal molecular complexity to be more comprehensively 
appreciated and assigned for the first time (Dulac and Axel, 1995; Zeisel et al., 2015). 
Defining Cell-Types in the Context of Cell-State Plasticity 
 Neuroscience is rapidly cataloging the transcriptional character of neuronal 
populations across wide brain regions, with systems-level approaches to collecting 
additional types of molecular information such as epigenomic and proteomic 
composition likely on the horizon. However, cellular identifies and their defining features 
are fully plastic (Takahashi and Yamanaka, 2006), and as such, defining cell-types by 
the presence of a certain feature or collection of features is inherently problematic. 
Furthermore, the specificity of cell-type definitions is subjective to the resolution 
demanded by interpreter, as theoretically every individual cell within a population could 
be segregated by molecular features as surveyed in a particular moment of time. This 
challenge might be addressed by considering the intersection of functional and 
molecular specificity in ascribing cell-types, but this too is complicated by plastic 
considerations, especially in the brain where plasticity across circuits is complex and 
ongoing. Thus, a faithful cell-type designation cannot exist without prior assumptions. 
For the sake of simplification, however, a suitable cell-type definition should thus only 
consider features that are resilient to nearly all pressures through which the cell has the 
capacity survive, and similarly, cell-state can be defined as the collective response to 
any pressure—either homeostatic or allostatic—that enables survival within its context.
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CHAPTER 2. AN INTRODUCTION TO HIGH-THROUGHPUT 
SINGLE-CELL RNA SEQUENCING2 
Methods and Technologies: An Overview 
In order to achieve divergent functional specificity, the adult brain is comprised of 
a diverse catalog of neuronal cell-types that exhibit unique functional and morphological 
complexity. All neurons share the same genome within an individual, and interregional 
and intraregional neuronal diversity is therefore borne from distinct patterns of gene 
expression across cellular populations. Accordingly, the observation that unique 
transcriptional features can be used to discriminate unique functional populations in the 
brain has significant historical precedent (Edlund and Jessell, 1999; Fremeau et al., 
2001; Lewis et al., 1988; Lightman, 1988; Shirasaki and Pfaff, 2002; Sunkin et al., 2012; 
Tasic et al., 2016; Zeisel et al., 2015). However, it has become increasingly recognized 
that neuronal subtypes are often marked by either undescribed individual features or a 
multiplexed combination of features, thereby requiring sufficient numbers of unique cells 
to be profiled in order to achieve sufficient tissue-level resolution. Within the past few 
years, a number of high-throughput genomic strategies have enabled the examination 
of thousands-to-millions of cells simultaneously and at sufficient depth (Cao et al., 2017; 
Klein et al., 2015; Macosko et al., 2015; Rosenberg et al., 2018). This revolution in high-
throughput single-cell sequencing approaches, originally catalyzed by specialist 
                                               
2 Some material within this chapter will appear as part of a book; citation as follows: Rodriguez-Romaguera J, 
Namboodiri VMK, Basiri ML, Stamatakis AM, Stuber GD. 2020. Developments from bulk optogenetics to single-cell 
strategies to dissect the neural circuits that underlie aberrant motivational states. Cold Spring Harb Perspect Med. 
doi: 10.1101/cshperspect/2020/03972. 
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methods, have recently reached a point in which they have become accessible to most 
labs both in terms of technical prerequisites and cost. Although this discussion will be 
focused on single-cell RNA-sequencing, similarly notable advances have been made in 
other avenues of single-cell genomics including single-cell DNA-sequencing (Lan et al., 
2017) and single-cell epigenomics (Cusanovich et al., 2015; Stevens et al., 2017). 
Preceding to the development of RNA-sequencing, genome-wide gene 
expression profiling of either bulk tissues or single-cell extracts generally relied on 
analog imaging-based hybridization technologies, primarily in the form of DNA 
microarrays (Churchill, 2002; Schena et al., 1995; Taub et al., 1983). To dissect the 
heterogeneity of neural tissues, pioneering single-cell microarray methods were applied 
to the exploration of neuronal transcriptional programs (Iscove et al., 2002; Kamme et 
al., 2003; Tietjen et al., 2003). However, these hybridization-based methods required 
bait sequences to be known beforehand and were subject to oversaturation by highly-
expressed genes or poor detection of rare transcripts, confounding quantitative 
sensitivity (Kukurba and Montgomery, 2015). Microarrays were eventually replaced by 
Sanger sequencing-based methods such as low-throughput and quantitative 
sequencing of complementary DNA (cDNA) clones (Expressed Sequence Tag libraries) 
or sequencing of chemically-tagged and captured cDNA pools (i.e. Serial Analysis of 
Gene Expression, Cap Analysis Gene Expression) (Adams et al., 1991; Itoh et al., 
1994; Shendure, 2008; Shiraki et al., 2003; Velculescu et al., 1995). Although tag-based 
methods allowed for precise digital quantification of gene expression levels, they were 
isoform-insensitive and generally produced short reads that were difficult to align to a 
reference genome. Furthermore, all Sanger-based gene expression profiling techniques 
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required relatively large amounts of RNA to be isolated, were manually intensive, and 
were limited by the high cost-per-base of Sanger sequencing (Wang et al., 2009). 
Genome-wide gene expression analysis was eventually revolutionized by the 
development of high-throughput next-generation sequencing, which allowed for rapid 
massively-parallel sequencing of polynucleotide sequences at a small fraction of the 
cost of Sanger sequencing (Bentley, 2008; von Bubnoff, 2008). This quickly enabled 
deep RNA-sequencing of bulk tissue lysates, allowing for the interrogation of 
transcriptional events at high transcriptomic coverage and resolution for the first time 
(Kukurba and Montgomery, 2015; Lister et al., 2008; Mortazavi et al., 2008; 
Nagalakshmi, 2008; Shendure, 2008; Wang et al., 2009; Wilhelm, 2008). The basic 
technical and analytical principles of these bulk RNA-sequencing approaches laid the 
groundwork for more sophisticated single-cell methods, and they continue to inform the 
principles of contemporary high-throughput single-cell RNA-sequencing strategies. 
The first single-cell RNA-sequencing experiments relied on manual microscopic 
selection of individual cells (Kurimoto, 2006; Kurimoto et al., 2007; Tang et al., 2009). 
Although at least one-hundred single-cell RNA-sequencing methods have been 
described to date3, these methods are generally all comprised of a workflow similar to 
that of bulk RNA-sequencing approaches. Briefly, RNA is isolated from individual 
cellular or nuclear lysates, reverse transcribed, amplified, and prepared for next-
generation sequencing. The primary differences in these methods is in their cDNA 
amplification technologies and in their approaches to the highly-multiplexed capture of 
                                               
3 For a community-complied list of high-throughput single-cell RNA-sequencing methods, see: 




RNA from individual cells. The most common of these high-throughput single-cell 
sequencing approaches can generally be grouped into either droplet-based (Klein et al., 
2015; Macosko et al., 2015) or plate-based methods (Campbell et al., 2017; Cao et al., 
2017; Moffitt et al., 2018; Rosenberg et al., 2018). Droplet-based methods use 
microfluidic devices to deliver cells, reagents, and barcoded oligonucleotide-coated 
microparticles into nanoliter-sized emulsions which serve as a compartment for the 
capture of polyadenylated transcripts. These barcoded microparticles are then pooled 
and subjected to solid-phase cDNA amplification to ultimately generate sequencing 
libraries. Rather than relying on microfluidic devices to isolate cells, plate-based 
strategies instead generate multiplexed sequencing libraries by distributing cells into 96-
well plates and performing multiple successive rounds of in situ reverse transcription 
and barcode ligation, with pooling and redistribution of cells between each round. Thus, 
both droplet-based and plate-based strategies are able to generate next generation 
sequencing libraries from thousands-to-millions of cells in which each library molecule is 
barcoded by transcript-, cell-, and sample-of-origin.  
The choice of droplet-based versus plate-based strategy depends on factors 
including the amount of starting material, the required depth of transcriptome coverage, 
the number of cells to be achieved, cost, and convenience. In general, plate-based 
strategies require considerably more starting material and sacrifice depth of coverage 
but can be used to produce data from a greater number of individual cells at a 
significantly lower cost. Although home-built droplet microfluidic-based strategies often 
demand a significant amount of technical expertise and investment, they have recently 
been largely replaced by commercial options that dramatically simplify the technical 
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process, provide consistent performance across datasets, and generate high-quality 
data at greater depth (Kim et al., 2019; Sharma et al., 2020). However, such 
commercial options require specialized proprietary equipment and significant reagent 
costs, dramatically increasing the cost-per-cell. Ultimately, however, the choice of 
droplet-based or plate-based strategy depends mostly on experimental requirements. 
For small brain nuclei or samples that are cost- or time-prohibitive to generate, 
commercial droplet-based strategies may be most appropriate; plate-based strategies, 
on the other hand may be best suited to studies of large brain regions requiring 
transcriptomes to be generated from a very large number of individual cells.  
In terms of data robustness, the primary factor determining the statistical 
resolution of feature identification and cell-type classification is the balance between 
depth of transcriptome coverage and total number of cells (Svensson et al., 2017, 2017; 
Zhang et al., 2020). Very roughly, shallow depth can be compensated for by generating 
transcriptomes from a large number of cells, while a fewer number of cells in a dataset 
can be overcome by sampling each cell’s transcriptome more deeply. Ultimately, 
however, high-throughput single-cell RNA-sequencing methods are considered shallow 
as compared to manual methods (Hodge et al., 2019; Tasic et al., 2016; Zeisel et al., 
2015), and this lack of depth is overcome by observing and statistically grouping a large 
number of cells based on transcriptional similarity. The size and complex nature of data 
generated from single-cell RNA-sequencing experiments has mandated the 
development of novel computational approaches to interpret the data (Butler et al., 
2018; Macosko et al., 2015; Qiu et al., 2017; Vieth et al., 2019; Ziegenhain et al., 2017), 
and standardized analytical pipelines are validated for most routine applications. 
 11 
Molecular biology of single-cell RNA-sequencing 
The transcriptome encompasses a diverse array of RNA species, with biological 
information encoded in both the structure and conditional abundance of each molecule. 
Within a cell, rare transcripts are not necessarily less biologically significant than 
abundant transcripts; the number of molecules of an RNA species present at a 
particular moment in time is determined by their partially-inherent cytoplasmic stabilities, 
as dictated by production and decay kinetics. Therefore, in order to faithfully observe 
transcriptional events within an individual cell, sufficient numbers of molecules must be 
sampled and quantified within sensitivity and saturation limits that reflect the dynamic 
range of cellular transcriptional signals. 
The generation of sequencing libraries from individual cells has been traditionally 
limited by the low amount of input RNA present in single-cell lysates, requiring either 
multiple successive rounds of linear isothermal amplification (Eberwine et al., 1992; Van 
Gelder et al., 1990) or exponential amplification (Dulac and Axel, 1995) of reverse 
transcription products to achieve sufficient product for sequencing. However, 
amplification-dependent methods produce artifacts that mask biological variation 
including amplification of primer concatamers or misprimed genomic reads, jackpot 
events resulting from stochastic early amplification bias, and signal oversaturation by 
abundant transcripts (Iscove et al., 2002). Such technical confounders are inherent to 
the overamplification of low-input substrates, introducing significant variability across 
samples and complicating the accurate quantification of molecules both within and 
across individual cells. In an effort to manage artifacts produced by excessive rounds of 
amplification, directional methods in which reverse transcribed strands are first labeled 
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with primer-embedded promoter sequences prior to cDNA amplification allow for fewer 
rounds of amplification to be used (Kurimoto, 2006). However, these early methods 
generally only provide short-read coverage of either the 3’ or 5’ ends of transcripts, 
complicating read mapping and hindering the analysis of polymorphism and isoform 
diversity (Islam et al., 2011; Kurimoto, 2006; Tang et al., 2009). 
A number of methods have been developed to minimize amplification artifacts, 
increase quantitative precision, and generate cDNA libraries that represent full-length 
coverage across transcripts (Hashimshony et al., 2012; Islam et al., 2011; Kivioja et al., 
2012; Picelli et al., 2013, 2014; Ramsköld et al., 2012; Tang et al., 2009). These 
methods primarily differ in the types of RNA molecules captured, cDNA coverage bias, 
amplification method, strand specificity, and quantification strategy. Consequently, 
contemporary high-throughput methods combine aspects of multiple base 
methodologies (Hedlund and Deng, 2018; Macosko et al., 2015; Ziegenhain et al., 
2017). The most common contemporary molecular platform for both manual and high-
throughput single-cell RNA-sequencing is based on a template-switching PCR approach 
to cDNA amplification (Switching Mechanism at 5′ End of RNA Template; SMART; 
SMART-seq), and multiple improvements based on its components have been made as 
single-cell RNA-sequencing approaches have evolved (Islam et al., 2011; Kim et al., 
2019; Kivioja et al., 2012; Macosko et al., 2015; Picelli et al., 2013, 2014; Ramsköld et 
al., 2012; Sharma et al., 2020).  
Most single-cell RNA-sequencing methods, including SMART-seq, begin with the 
first-strand synthesis of cDNA by reverse transcription of polyadenylated transcripts via 
priming with deoxythymidine oligonucleotides (oligodT). Priming against polyadenylated 
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transcripts enriches for pre-mRNA, mRNA, and lncRNA while avoiding ribosomal RNA, 
which accounts for the vast majority of cytoplasmic RNA mass and would otherwise 
saturate library pools (Moore and Proudfoot, 2009; Slomovic, 2006; Yang et al., 2011). 
In SMART-based methods, second-strand synthesis is achieved by leveraging the 
transferase and strand-switching activity of Moloney Murine Leukemia Virus (MMLV) 
reverse transcriptase (Ramsköld et al., 2012; Zhu et al., 2001). During first-strand 
synthesis, the terminal transferase activity of MMLV reverse transcriptase adds a non-
templated extension of cytosine nucleotides to the 3′ of the first strand. Second-strand 
synthesis uses this cytosine extension as a priming site to create an extended template 
with PCR adaptor sequences. MMLV reverse transcriptase then switches templates and 
completes transcription to generate full-length cDNA molecules containing full 5’ regions 
and adaptor sequences. Following second-strand synthesis, molecules are purified and 
amplified via conventional high-fidelity PCR (Brandariz-Fontes et al., 2015; Filges et al., 
2019). Prior to sequencing, amplified library pools are fragmented and tagged with the 
appropriate sequencing adaptors following standard protocols for next-generation 
sequencing library construction. 
Computational biology of single-cell RNA-sequencing 
 Single-cell RNA-sequencing experiments yield complex datasets produced by 
the highly-multiplexed amplification of faint signals that are often near the quantitative 
limit of detection. Such datasets are usually comprised of millions or billions of 
sequencing sampling events, and these events must be faithfully distilled into 
meaningful, consistent, and biologically-reliable observations. Generalized single-cell 
RNA-sequencing analysis pipelines involve the filtering of low quality cells and collision 
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events, normalization across cells to correct for technical artifacts, clustering of cells on 
reduced gene expression components, and feature identification across clusters. 
Normalization, artifacts, collisions, and quality 
 Preprocessing and quality control of high-throughput single-cell RNA-sequencing 
data is an essential step in transforming sequencing observations to biologically-
meaningful information. Given the high-sensitivity of next-generation sequencing 
technologies and the enormous number of total observations, variation in experimental 
and technical factors has the inclination to generate confounding effects that mask true 
biological variability. Importantly, observed differences in depth of sequencing and 
molecules detected across cell-types can influence the quality of unsupervised 
downstream analyses (Vallejos et al., 2017). These variations are tied to the inherent 
sparsity of single-cell datasets, where stochastic detection, zero-inflation of values, and 
saturation with abundant reads amplifies the effects of technical noise and masks rare 
sampling events (Kharchenko et al., 2014; L. Lun et al., 2016; Pierson and Yau, 2015; 
Vallejos et al., 2017). Consequently, normalization of single-cell RNA-sequencing 
datasets represents a critical step in controlling for noise and artifacts that may mask 
true biological signals (Bacher and Kendziorski, 2016; Bacher et al., 2017; Brennecke et 
al., 2013; Kharchenko et al., 2014).  
 In the rapid escalation of single-cell RNA-sequencing applications, data 
normalization strategies initially relied on methods originally developed for bulk RNA-
sequencing datasets in which scaling factors are calculated globally across the entire 
dataset (Leek et al., 2012; Macosko et al., 2015; Vallejos et al., 2017). However, given 
the heterogeneity of single-cell RNA-sequencing datasets, more contemporary methods 
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to normalize datasets without regressing out true biological variability between cells 
have been developed. These methods either seek to adjust molecule counts according 
to estimated scaling factors for individual cells (Vallejos et al., 2015, 2017) or to model 
signal and dropout events probabilistically for regression (Kharchenko et al., 2014). 
Typically, these models applied to single-cell RNA-sequencing data assume either a 
negative binomial or zero-inflated distribution for normalization. 
 Prior to data normalization, preprocessing steps for single-cell RNA-sequencing 
data includes the removal of low-quality cells. In general, cells containing a low 
abundance of unique counts or features are removed using a subjective threshold. 
Further, cells containing a high percentage of reads originating from the mitochondrial 
genome are removed, as these are thought to be enriched in distressed cells (Galluzzi 
et al., 2012; Ilicic et al., 2016).  
 In addition to the removal of low-quality cells, single-cell RNA-sequencing data 
quality can also be improved in preprocessing by the removal of doublet or collision 
events. These events occur when more than one cell receives the same cellular 
barcode, such as by occupying the same droplet during microfluidic-based single-cell 
RNA-sequencing protocols. In general, algorithmic doublet removal strategies generally 
seek to identify these cells by automatically clustering the cells at cell-type resolution 
and subsequently classifying these cells against a pool of predicted stereotyped 
doublets (DePasquale et al., 2019; Gayoso and Shor, 2019; Wolock et al., 2019). 
Therefore, cells containing transcriptional features representative of more than one cell-
type are predicted to be artefactual combinations of more than one cell. Notably, such 
methods can only identify heterotypic doublets resulting from the collision of more than 
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one cell-type. However, both heterotypic and homotypic doublets can be identified by 
performing sample indexing of cell pools at the bench prior to loading into the single-cell 
RNA-sequencing protocol (McGinnis et al., 2019; Stoeckius et al., 2017). 
Clustering 
 An initial goal in the analysis of most single-cell RNA-sequencing datasets is the 
classification of cells according to transcriptional similarity. Nevertheless, clustering cells 
is inherently complicated by the high dimensionality of single-cell transcriptome data 
and the sparsity of observations. To overcome this, correlated gene expression 
dimensions are reduced by principal components analysis (PCA) prior to clustering in 
most single-cell RNA-sequencing analysis pipelines (Macosko et al., 2015; Shalek et 
al., 2014). After PCA, clustering is typically performed on a shared nearest-neighbor 
graph calculated either on principal components or in gene expression space (Shekhar 
et al., 2016). This graph is then used as the input for clustering approaches, the most 
widely used of which is the Louvain community detection algorithm (Kiselev et al., 2019; 
Macosko et al., 2015; Shekhar et al., 2016). 
 To visualize cells, a second round of dimensionality reduction is applied on a 
subset of retained principal components that explain a substantial amount of the total 
variance in the data. This reduction is performed using nonlinear transformations, which 
allow for better visualization of the data (Kiselev et al., 2019). The most commonly used 
reduction and visualization methods are t-distributed stochastic neighbor embedding (t-
SNE) (Maaten and Hinton, 2008) or Uniform Manifold Approximation and Projection 
(UMAP) (McInnes et al., 2018). Of note, unlike t-SNE, which does not preserve 
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information in the distances and densities between cells, UMAP allows for the 
visualization of relationships across cells projected onto the same space. 
Inference of cell-state dynamics 
 Another goal of single-cell RNA-sequencing experiments is often the examination 
of cell-state changes either during lineage specification or in response to a chronic 
perturbation (Loo et al., 2019; Qiu et al., 2017; Rossi et al., 2019; Sharma et al., 2020). 
Roughly, these methods seek to identify transcriptional trajectories across populations 
of cells either by ordering cells according to transcriptional similarity (Qiu et al., 2017; 
Trapnell et al., 2014) or by determining the direction of gene expression changes by 
comparing genewise abundances of nascent and mature transcripts to assign weighted 
transcriptional vectors across cells (La Manno et al., 2018). Using these methods, 
critical mechanistic regulators of developmental or allostatic states can be identified by 
examining endpoints and nodes in cellular trajectories. 
Applications in Neural Systems 
Single-cell RNA-sequencing provides a novel set of approaches to address 
common challenges in systems neuroscience. For example, by examining differential 
gene expression across molecularly-defined cell-types, transcriptomic signatures of 
acute and chronic experimental manipulations can be identified within specific neuronal 
cell-types (Avey et al., 2018; Ocasio et al., 2019; Rossi et al., 2019). Furthermore, 
neuronal subpopulations activated by an acute stimulus can be identified by examining 
immediate-early gene expression across neuronal subtypes (Hashikawa et al., 2020; 
Hrvatin et al., 2018; Kim et al., 2019; Wu et al., 2017), and neuronal projection 
populations can be discovered by virally-labeling projections and inspecting the 
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distribution of virally-encoded sequences across neuronal subtypes at the projection 
source (Kebschull et al., 2016). Thus, in systems neuroscience, at minimum, single-cell 
RNA-sequencing can be leveraged to identify precise transcriptionally-defined neuronal 
subtypes within brain regions of interest, describe which subtypes serve as functional 
substrates during experimental conditions, and to distinguish specific projection 
populations within heterogeneous brain regions. These methods are poised to become 
a routine part of the circuit neuroscientist’s toolkit in a manner that will dramatically aid 
in the specificity of circuit dissection.
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CHAPTER 3. REMODELING OF THE LATERAL HYPOTHALAMIC AREA 
TRANSCRIPTIONAL LANDSCAPE IN OBESITY4 
Introduction 
Obesity affects more than 500 million adults worldwide (Finucane et al., 2011), and 
its comorbidities present a pressing medical challenge (Flegal et al., 2004; Kopelman, 
2000) that causes a staggering economic burden (Finkelstein et al., 2005). Despite its 
increasing prevalence and the consensus that the brain regulates food intake and energy 
homeostasis (Flegal et al., 2016), the neural adaptations governing obesity are unknown. 
The lateral hypothalamic area (LHA) is a well-conserved brain region that orchestrates 
feeding, energy homeostasis, and reward-related behaviors in mammals (Anand et al., 
1955; Hoebel and Teitelbaum, 1962; Jennings et al., 2013; Margules and Olds, 1962; 
Woods, 1998). The LHA is highly molecularly diverse (Mickelsen et al., 2019; Stuber and 
Wise, 2016) and synaptically connected with wide-ranging subcortical brain regions that 
are critical for fear and anxiety, aversion, and reward (Nieh et al., 2015, 2016; Rossi and 
Stuber, 2018; Stamatakis et al., 2016). Until recently, no consensus has existed regarding 
the molecular heterogeneity of LHA cell-types. LHA glutamatergic neurons, expressing 
vesicular glutamate transporter type-2 (Vglut2; LHAVglut2), can influence food intake, body 
weight, reward, and aversion (Stuber and Wise, 2016). Importantly, LHAVglut2 activation 
                                               
4 Material within this chapter previously appeared in part in a paper published in the journal Science. The original 
citation is as follows: Rossi, M.A., Basiri, M.L., McHenry, J.A., Kosyk, O., Otis, J.M., van den Munkhof, H.E., Bryois, 
J., Hübel, C., Breen, G., Guo, W., et al. (2019). Obesity remodels activity and transcriptional state of a lateral 
hypothalamic brake on feeding. Science 364, 1271. 
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suppresses feeding (Jennings et al., 2013), and the integrity of LHAVglut2 cells is critical for 
mitigating weight gain in response to caloric surfeit (Stamatakis et al., 2016). 
Here, we apply high-throughput droplet-based single-cell RNA-sequencing 
(Macosko et al., 2015) to track transcriptional changes occurring during obesity and 
demonstrate that high fat diet (HFD) robustly modifies the transcriptional landscape of 
LHAVglut2 neurons during obesity. We find that HFD-induced transcriptional events in 
these neurons predict altered activity dynamics, and using longitudinal in vivo two-photon 
calcium imaging, show that responses of LHAVglut2 neurons to rewards are greatly 
attenuated over the course of weight gain on HFD. We further identify 15 unique subtypes 
of LHAVglut2 neurons and characterize how these glutamatergic subpopulations are 
differentially and uniquely impacted by HFD. We then leverage insights from single-cell 
RNA-sequencing to selectively disrupt the neuropeptide Neurotensin within LHAVglut2 
neurons using virally-delivered SaCas9, which subsequently mitigates weight gain and 
caloric intake on HFD.  
Collectively, these data demonstrate how diet alters the transcriptional landscape 
of the LHA and disrupts the reward encoding properties of an endogenous brake on 
feeding to promote over-eating and obesity. More generally, these data demonstrate how 
physiologically-relevant pressures, such as dietary influences, can exert a widespread 
influence on cell-state plasticity in neuronal substrates that govern associated behavioral 
processes. This work also serves as proof-of-principle for how high-throughput single-cell 
RNA-sequencing can be applied to identify specific candidate features for biological 




Drop-Seq Identifies Canonical Cell-Types in the Lateral Hypothalamic Area 
To probe transcriptional changes within the LHA following chronic HFD exposure, 
we used high-throughput microfluidic droplet-based single-cell RNA-sequencing (Drop-
Seq, Figure 1 and Figure 2) to transcriptionally profile 20,194 LHA cells in control and 
HFD mice (Figure 3A) to a median of 619 unique genes and 961 unique transcripts per 
cell. Cells were clustered based on highly variable gene expression using principal 
component analysis. Dimensionality was reduced and the data were visualized by 
clustering in t-SNE space (see Methods) (Maaten and Hinton, 2008). In agreement with 
previous transcriptional characterizations of mouse brain regions (Gokce et al., 2016; 
Hrvatin et al., 2018; Mickelsen et al., 2019; Wu et al., 2017), we identified transcriptionally-
distinct resident cell-types of LHA tissue including neuronal, glial, and stromal cell 
classes, each expressing canonical markers for each cell-type (Figure 3C-D). We also 
observe previously-described functionally-distinct major subclasses LHA neurons 
including a large population of GABAergic (Vgat) and glutamatergic (Vglut2) neurons, as 
well as separate discrete populations expressing Orexin/Hypocretin (Hcrt) and Pro-
Melanin Concentrating Hormone (Pmch) (Figure 3C and 3E) (Aston-Jones et al., 2010; 
Bittencourt et al., 1992; Elias et al., 1998; Jego et al., 2013; de Lecea et al., 1998; Qu et 
al., 1996). GABAergic and Glutamatergic cells exhibited similar proportional 
representation between sequencing and fluorescent in situ hybridization (Figure 3F), 
suggesting that the droplet-based single-cell RNA-sequencing protocol and statistical 
clustering approach maintained biologically-valid relative proportions of cell-types across 
the neuronal populations. 
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Transcriptional Tuning Across Lateral Hypothalamic Cell-Types During Obesity 
Obesity is a multifaceted physiological perturbation with metabolic, hormonal, 
immune, and behavioral features (Kahn and Flier, 2000; McLaughlin et al., 2017; Uranga 
and Keller, 2019). As such, obesity presents unpredictable heterogeneous pressures on 
the neural systems regulating food intake and energy balance. Consistent with the 
complex and distributed nature of chronic HFD exposure, we found that all resident cell 
classes of the LHA display distinctive, non-overlapping patterns of transcriptional 
modification following chronic HFD (Figure 4A-B). However, of all cell-types, 
glutamatergic neurons, expressing Vesicular Glutamate Transporter Type-2 (Vglut2 
(Slc17a6); LHAVglut2), exhibited significant changes in the greatest degree and proportion 
of genes across all LHA cell-types (Figure 4A-D). Of the major neuronal populations, 
LHAVglut2 neurons also exhibited the most statistically significant distribution of HFD-
induced alterations in gene expression (Figure 4C). Consistently, LHAVglut2 neurons also 
contained the most significant gene-level genetic association with human body mass 
index (BMI) (Figure 4E), suggesting that similar alterations within LHAVglut2 neurons may 
underlie human obesity. This agrees with previous reports in which diet alters 
hypothalamic neurons involved in energy balance (Chen et al., 2017; Henry et al., 2015). 
Together, these data suggest that LHAVglut2 neurons are especially responsive to obesity-
induced perturbations in transcriptional state. 
 To further understand the effect of HFD on LHAVglut2 gene expression programs, 
we used LHAVglut2 cells to construct learned cell-state trajectories in which cells were 
ordered according to degree of transcriptional change, represented in pseudotime (Qiu 
et al., 2017; Trapnell et al., 2014) (Figure 4F). HFD cells were enriched at later 
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pseudotimes and displayed pseudotime-dependent changes in gene expression 
(Figure 4G), suggesting that a widespread gradient of allostatic changes occur within 
LHAVglut2 neurons during chronic HFD exposure. To identify features underlying these 
changes, we tested genes differentially-expressed across the LHAVglut2 pseudotime 
trajectory for enrichment across functional annotation classes and examined classes 
relevant to neuronal activity and function. We found that LHAVglut2 cells exhibited 
significant pseudotime-dependent alterations in annotations associated with neuronal 
activity including ion homeostasis, synaptic activity, and intracellular signaling (Figure 
4H and Figure 5) (Kuleshov et al., 2016). 
 Selective ablation of LHAVglut2 neurons potentiates the intake of calorically-dense 
food (Stamatakis et al., 2016). Because LHAVglut2 neurons were particularly sensitive to 
chronic HFD (Figure 4) and displayed significant changes in functional annotations 
classes associated with neuronal activity (Figure 4H), we sought to assess their natural 
activity dynamics during caloric reward consumption (Rossi et al., 2019). To test this, a 
virus encoding the fluorescent calcium reporter GCaMP6m (Chen et al., 2013) under 
the control of Cre (AAVdj-DIO-GCaMP6m) was infused into LHA of Vglut2-Cre mice. A 
gradient refractive index (GRIN) lens was implanted ~150 µm above the injection site, 
permitting optical access to LHAVglut2 neurons. Mice were maintained on either HFD or 
control diet for 12 weeks (Figure 4I). While control LHAVglut2 neurons maintained their 
responsivity to sucrose consumption, HFD LHAVglut2 neurons became progressively less 
responsive to sucrose (Figure 4J-K). Thus, as suggested by the transcriptional 
changes observed via single-cell RNA-sequencing, LHAVglut2 neurons alter their food 
reward encoding activity during obesity. 
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Distinct Transcriptional Representations of Obesity in Lateral Hypothalamic 
Glutamate Neuron Subtypes 
 
Based on known, partially-overlapping patterns of mRNA and protein expression 
within the LHA (Gerashchenko and Shiromani, 2004; Rossi and Stuber, 2018; Stuber and 
Wise, 2016), we hypothesized that the LHAVglut2 neuron population comprises distinct 
subtypes of glutamatergic neurons that may be differentially impacted by HFD. To identify 
subpopulations of LHAVglut2 cells, we isolated the cells from the Vglut2 cluster and 
reclustered the cells using similar approaches to those used for the clustering of all LHA 
cell-types. We discovered 15 transcriptionally-distinct LHAVglut2 neuron subclasses 
(Figure 6A-D). Across these, we identify the genes Dlk1, Calb2, Meis2, and Lhx1 as 
broad markers encompassing multiple LHA glutamatergic subclasses (Bedont et al., 
2014; Meister et al., 2013) (Figure 6D). As higher resolution, these broad glutamatergic 
subclasses are comprised of discrete subclasses that can largely be separated by unique, 
non-overlapping expression of the neuropeptides Neurotensin (Nts), Thyrotropin 
Releasing Hormone (Trh), Preprotachykinin-1 (Tac1), Proenkephalin (Penk), and 
Prepronociceptin (Pnoc) (Figure 6C-D), suggesting that these subclasses of LHAVglut2 
neurons may participate in more specialized neurocircuit functional activities. 
Considering the discrete distribution of features involved in gene regulation and 
neuromodulation (Figure 6C) in LHAVglut2 subclasses, we hypothesized that these 
subclasses of LHAVglut2 neurons would display differential transcriptional responses to 
HFD. We compared intracluster gene expression changes following HFD and found that 
each subtype of neurons exhibited significant variability in the proportion and magnitude 
of genes differentially-expressed (Figure 6G-H). These changes were found largely 
across separate groups of genes (Figure 7 and Figure 8). Since these subcluster-
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specific changes were observed across critical modulators of neuronal activity, including 
GABA and glutamate receptor subunits, neuropeptides, transcription factors, and G-
protein coupled receptors (Figure 7B-C and Figure 8), HFD and obesity may induce 
subcluster-specific reshaping of functional activity dynamics in the LHA. 
Viral SaCas9-Mediated Mutation of Neurotensin in Lateral Hypothalamic Glutamate 
Neurons Attenuates HFD-Induced Weight Gain 
 
 We next sought to leverage the discrete transcriptional events observed within 
LHAVglut2 subpopulations. We hypothesized that targeted functional manipulation of at 
least one of these subclasses should modify the HFD phenotype. One of the largest 
glutamatergic subclasses was marked by high expression of the neuropeptide Nts 
(LHAVglut2∷Nts) (Figure 6B-D), which has been previously described in the hypothalamic 
and systemic regulation of feeding behavior and obesity (Leinninger et al., 2011; Li et 
al., 2016). We observed that HFD significantly upregulates Nts expression within the 
LHAVglut2∷Nts cluster, as well as modifies the expression of Nts in other Nts-expressing 
LHAVglut2 subtypes (Figure 9A-C).  
 We hypothesized that loss-of-function mutation of Nts in these populations would 
modify obesity- or feeding-associated phenotypes. To test this, we designed a Cre-
inducible Staphylococcus aureus Cas9-based (SaCas9) (Friedland et al., 2015; Hunker 
et al., 2020; Ran et al., 2015) viral vector strategy (AAV5-DIO-Nts-Cas9) to target the 
Nts locus at its peptide-coding exon, which is predicted to produce a translation product 
terminating in a frameshift truncation prior to its neuropeptide domain and result in 
complete loss-of-function of Nts (Figure 9D). Injecting AAV5-DIO-Nts-Cas9 into the 
LHA of Vglut2-Cre+ mice did not affect food intake or body weight on a standard chow 
diet, but significantly mitigated weight gain on HFD by reducing food intake relative to 
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controls (Figure 9F-I). Viral SaCas9-mediated mutation of Nts in LHAVglut2 neurons did 
not affect body temperature, water mass, or lean mass (Figure 9J-K, M). These results 
are consistent with homozygous Nts deletions (Li et al., 2016), suggesting that this 
small population of LHAVglut2 neurons is sufficient to coordinate some of the peripheral 
Nts-dependent responses to HFD. Importantly, the phenotype induced by SaCas9 
mutation of Nts opposes the effect of viral ablation of LHAVglut2 neurons (Stamatakis et 
al., 2016), suggesting that the effect is specifically driven by Nts signaling by these 
neurons rather than reduced survivability secondary to infection with the SaCas9 virus.  
Discussion 
 While obesity represents a strong systemic pressure on cellular physiology 
throughout the body (Kahn and Flier, 2000; McLaughlin et al., 2017; Uranga and Keller, 
2019), the influence of obesity on brain transcriptional states at cellular resolution has 
not been previously described. Here, we show that LHA substrates are transcriptionally 
modified by chronic HFD, and that these changes occur in a highly cell-type-specific 
manner, with distinct transcriptional representations of obesity occurring across resident 
tissue cell-types and neuronal subtypes. By prioritizing these cell-types on multiple 
metrics of differential gene expression, we identify LHAVglut2 neurons as uniquely 
responsive to HFD manipulation and use transcriptional features to predict altered 
activity dynamics in these neurons in response to caloric reward. We further 
characterize LHAVglut2 neurons and identify molecularly-defined subtypes of glutamate 
neurons in the LHA and show that cell-type-specific manipulation of a gene that is 
differentially-expressed during obesity in these neurons (Nts) can attenuate HFD-
induced caloric intake, body fat composition, and weight gain. 
 27 
 Because LHAVglut2 activity is known to directly influence feeding (Jennings et al., 
2013) and the integrity of these cells is critical for weight gain in response to HFD 
(Stamatakis et al., 2016), we hypothesize that the excitatory LHAVglut2 signal represents 
the activation of a brake on feeding, which suppresses food intake. In accordance with 
this idea, we demonstrate for the first time that chronic HFD exposure dramatically 
alters the transcriptional profile of LHAVglut2 neurons and ultimately hinders the activity 
dynamics and reward encoding properties of these cells, thereby weakening an 
endogenous brake on feeding to promote over-eating and obesity. Consistent with the 
observation that anorexigenic signals are often negatively valenced (Rossi and Stuber, 
2018), mice avoid LHAVglut2 activation (Jennings et al., 2013; Nieh et al., 2016). 
Together, these results indicate that LHAVglut2 neurons are powerful negative regulators 
of motivated feeding whose natural function, activity dynamics, and transcriptional 
landscape are uniquely degraded during diet-induced obesity. As such, this 
anatomically and molecularly restricted group of cells represents a novel therapeutic 
target for the treatment of obesity and psychiatric eating disorders. 
 Although this analysis focuses on glutamatergic neurons, this dataset provides a 
rich resource for identifying biologically meaningful transcriptional alterations across 
additional LHA neuronal, glial, and stromal cell-types in response to HFD. In addition to 
regulating consummatory behavior for food during obesity, LHAVglut2 cells also contribute 
to aversion (Jennings et al., 2013; Lazaridis, 2019; Nieh et al., 2016; Trusel, 2019), but 
it remains unclear whether these two populations are segregated. Future studies could 
leverage this dataset to develop molecular and transgenic tools to manipulate more 
precise LHAVglut2 subpopulations in feeding and aversion. 
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 Notably, these experiments also show that cell-state responses to external 
pressures are inherently tied to cell-type definitions. Although, in some cases, this is 
obvious—such as amongst different cell-type lineages intermixed within a tissue—we 
find that this holds true even at high cellular molecular resolution. That is, even amongst 
cell-types that have been historically considered to be relatively similar such, as 
subclasses of excitatory neurons within an anatomically-defined brain subregion (LHA), 
we observe distinct, non-overlapping patterns of transcriptional modification in response 
to an exogenous pressure (HFD). These distinct transcriptional representations are 
observed even between cell-types that are more specifically-defined, such as within the 
broader subclasses of LHAVglut2 neurons. Given the multifaceted nature of HFD and 
obesity, as well as the circuit level complexity of neuronal systems, the distinct patterns 
of gene expression observed amongst similar cell-types in the brain may be tied to 
either inherent differences in the character of their responses to the same exogenous 
signals, cell-type encoded abilities in their capacity to respond to different obesity-
associated signals, circuit-level electrophysiological influences independent of 
exogenous signals that drive differential gene expression patterns, or more likely, a 
combination of all three scenarios. To investigate this, future work should aim to 
examine the contribution of discrete, well-defined pressures on functionally and 
anatomically-restricted neuronal systems, such as modulation of downstream or 
upstream circuit activities, or through the actions of ligands specific for neuronal 





Tissue Isolation and Drop-Seq 
 Male C57BL/6J mice 8 weeks old at the start of diet manipulation were 
maintained on either control or high fat diet for 9-16 weeks (n = 7/group). Mice were 
deeply anesthetized with 390 g/kg sodium pentobarbital, 500 mg/kg phenytoin sodium 
and rapidly transcardially perfused with 20 mL ice-cold sodium-substituted aCSF 
(NMDG-aCSF) containing 96 mM N-methyl-D-glucamine (NMDG), 2.5 mM KCl, 1.35 
mM NaH2PO4, 30 mM NaHCO3, 20 mM HEPES, 25 mM glucose, 2 mM thiourea, 5 mM 
Na+ascorbate, 3 mM Na+pyruvate, 0.6 mM glutathione-ethyl-ester, 2 mM N-acetyl-
cysteine, 0.5 mM CaCl2, 10 mM MgSO4, and adjusted to pH 7.35–7.40, 300-305 mOsm 
(Rossi et al., 2019; Ting et al., 2014). Brains were isolated and six 280 μm sections 
through the LHA were collected in ice-cold NMDG-aCSF on a Leica VT1200 vibratome. 
Sections were allowed to recover in carbogen-buffered NMDG-aCSF containing 500 nM 
TTX, 10 μM APV, 10 μM DNQX (NMDG-aCSF-R) to reduce excitotoxicity activity at 
room temperature for 40 minutes. After recovery, LHA tissue was isolated with Palkovitz 
punches and incubated in NMDG-aCSF-R containing 1.0 mg/mL pronase for 35 
minutes at 30ºC. Following digestion, tissue was transferred to 1.0 mL NMDG-aCSF-R 
supplemented with 0.05% bovine serum albumen (NMDG-aCSF-BSA) and 
mechanically dissociated with a borosilicate patch pipet fire-polished to an internal 
diameter of 200-300 μm. The suspension was washed in 12 mL NMDG-aCSF-BSA, 
sedimented at 220 x g for 6 minutes at 18ºC, and immediately resuspended at a final 
concentration of 400 cells/μL in NMDG-aCSF-BSA for single-cell capture. 
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 Drop-Seq was performed as originally described, with minor modifications 
(Macosko et al., 2015). Briefly, cells were loaded Single-cell capture was performed on 
a glass microfluidics device (Dolomite Microfluidics, Royston, UK) with flow rates for set 
to manufacturer recommendations. Beads were loaded at a concentration of 390 
beads/μL. Reverse transcription, exonuclease I digestion, and PCR were performed as 
in (Macosko et al., 2015) with one additional cycle added to the second stage of 
amplification. Following PCR, products were pooled by animal, purified on SPRI beads 
(Agilent) at ratios described in (Macosko et al., 2015), and indexed following Nextera XT 
Tagmentation instructions with 750 pg input per reaction. Tagmentation products were 
double purified on solid-phase reversible immobilization (SPRI) beads using a 
negative/positive selection strategy to retain species between 300-600 bp, as quantified 
with an Agilent Bioanalyzer 2100 High Sensitivity DNA assay. Final libraries were 
pooled by mass proportional to the estimated number of cells per pool member as 
quantified by a Qubit dsDNA High Sensitivity Assay. Sequencing was performed at the 
University of North Carolina at Chapel Hill High Throughput Sequencing Facility on an 
lllumina HiSeq2500 using Paired-End 2x50 Rapid Run v2 chemistry. 
Single-Cell RNA-Sequencing Clustering and Analysis 
 Demultiplexing was performed with 1 mismatch allowed using Illumina bcl2fastq 
v2.18.0.12. Initial processing and generation of digital expression matrices was 
performed using Drop-Seq _tools v1.12 and Picard Tools v2.2.4 as described in 
(Macosko et al., 2015). Alignment was performed using STAR v2.4.2a with 72 GB of 
RAM and 16 threads. 
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 Clustering was performed using a combination of Seurat v1.4.0.16 and custom 
code in R v3.3.2 unless otherwise noted. For clustering of all cells (Figure 2-3), cells 
were filtered by ≤ 5,000 and ≥ 200 unique genes, ≤ 15,000 unique molecules, and ≤ 10 
percent mitochondrial reads; for re-clustering of glutamatergic neurons (Figures 4-8), 
cells in the glutamate cluster were filtered by ≤ 5,000 and ≥ 500 unique genes, ≤ 15,000 
unique molecules, and ≤ 5 percent mitochondrial reads. Filtered data were scaled to the 
median number of unique molecules and log(x+1) transformed. Zero-variance genes 
were removed from the data, and batch correction was performed with ComBat from the 
SVA v3.220 package using parametric adjustments on a model matrix containing 
sequencing pool, total number of unique genes and molecules, and percent 
mitochondrial reads (Johnson et al., 2007; Leek et al., 2012) (Figure 2C-E). Batches for 
clustering of all cells and for glutamate re-clustering were defined as described. Relative 
log expression by cell and mean expression correlation across animals were used to 
assess correction quality (Figure 2). Only genes detected in all animals by group were 
included in downstream analysis. 
 Highly variable genes were selected as described in (Brennecke et al., 2013) 
using an implementation in the package M3Drop v1.0.0 (Andrews and Hemberg, 2019) 
with a false discovery rate of 0.01 and a minimum dispersion of 0.5. These genes were 
used as the basis for principal components analysis. Cluster calling was performed on 
principal components using the Louvain algorithm with multilevel refinement (Rodriguez 
and Laio, 2014; Rotta and Noack, 2011; Šubelj and Bajec, 2011) and default settings. 
Principal components were reduced and visualized via t-SNE using the first 100 
components and a resolution of 0.5 (Figures 2-3), or the first 35 components and a 
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resolution of 2.5 (Figures 4-8) under default settings (Maaten and Hinton, 2008). 
Clusters were reordered based on a dendrogram estimated on a hierarchically-clustered 
distance matrix constructed on all genes (Figures 2-3) or highly variable genes 
(Figures 4-8). For glutamate re-clustering the confidence of dendrogram splits was 
assessed using the out-of-bag error for a random forest classifier trained on all internal 
nodes. For glutamate re-clustering, children of one node with an out-of-bag error 
outside of Tukey’s upper limit were merged. One non-glutamatergic cluster and one 
cluster with < 50 cells were ignored from subsequent analyses (Figure 6A, gray). 
 Feature discovery was performed using a likelihood-ratio test for single-cell data 
as implemented in Seurat (Macosko et al., 2015; McDavid et al., 2013). For cluster 
features, all genes in each cluster were tested against those in either the nearest cluster 
or node in the dendrogram tree. For group features, intra-cluster group comparisons 
were performed using the same test. In the clustering of all cells, one neuronal cluster 
comprising 3.72% of all neurons lacked high confidence markers and was not further 
analyzed (Figure 3C, gray). Comparisons of gene expression levels between groups 
were performed on inverse hyperbolic sine (asinh) transformed data (Amir et al., 2013; 
Hoffman et al., 2012; Rossi et al., 2019). 
 For gene x; asinh fold-change (asinhFC) was defined as: 
 
 Signal-to-noise ratio (Figure 4A and Figure 6G) was defined as: 
 
 where HF = high fat diet group expression and C = control group expression. 












SNR =  
asinh xC( )
σ
asinh XHF( )−median asinh XC( )( )
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 All steps from prepossessing to the generation of digital expression matrices 
were run on a Dell blade-based cluster running RedHat Enterprise Linux 5.6. Cluster 
calling and t-SNE were run on a similar cluster running RedHat Enterprise Linux 7.3. All 
other steps were performed on an Apple MacBook Pro running macOS 10.13.3. 
Functional Annotations and Pseudotime Analysis 
 Differentially-expressed genes (DEGs) with p ≤ 0.001 were used as input for 
gene-set analysis (Figure 4H). Gene-set analysis was performed using the online tool 
ENRICHr (http://amp.pharm.mssm.edu/Enrichr/) (Golden et al., 2017; Hoffman et al., 
2012). Adjusted p-values from ENRICHr were used to select significant terms from the 
following annotation databases: a, GO_Biological_Process_2018, s, 
GO_Cellular_Component_2018, u, GO_Molecular_Function_2018, x, KEGG_2016, r, 
Panther_2016, µ, Reactome_2016. 
 Pseudotime analysis was performed using Monocle v2.2.0 (Qiu et al., 2017; 
Trapnell et al., 2014) (Figure 4F-G and Figure 5). Briefly, cells from the glutamate 
cluster were selected and filtered for cells containing ≤ 5,000 and ≥ 500 unique genes, ≤ 
15,000 unique molecules, and ≤ 5 percent mitochondrial reads. Raw counts were fitted 
to a negative binomial distribution with fixed variance and size factors for individual cells 
were estimated using a mean-geometric-mean-total calculation. DEGs between control 
and HFD were estimated on a dispersion model and those with q ≤ 0.01 and detected in 
at least 10% of cells were used for pseudotime ordering. Trajectories were constructed 




Single-Cell GWAS Association 
 We used MAGMA (v1.06) as previously described to identify cell-types 
associated with BMI (Coleman et al., 2019; de Leeuw et al., 2015; Skene et al., 2018). 
The GWAS on BMI was a cross-sectional analysis of 353,972 European participants 
from the UK Biobank. Body composition was assessed using Tanita BC-418 MA scale 
(Tanita Corporation, Arlington Height, IL). We included 7,794,483 genotyped and 
imputed SNPs and insertion-deletion variants with a minor allele frequency of 1% 
(referred to as SNPs). We excluded pregnant participants or females after hysterectomy 
and covaried for factors related to assessment center, genotyping batch, smoking 
status, alcohol consumption, menopause, and for continuous measures of age, and 
socioeconomic status (measured by the Townsend Deprivation Index) (Townsend, 
1987). We accounted for underlying population stratification by including the first six 
ancestry PCs, calculated on the European subsample. We used BGENIE v1.2 
(https://jmarchini.org/bgenie) for sex-specific analyses and meta-analyzed these sex-
specific GWASs using METAL (Bycroft et al., 2018; Willer et al., 2010) 
(http://csg.sph.umich.edu/abecasis/metal). 
Linkage disequilibrium (LD) score regression (Bulik-Sullivan, 2015) estimated 
SNP-h2 for BMI was 21.9% (SE = 0.7%), the intercept 1.09 (SE = 0.01), and the 
attenuation ratio 0.06 (SE = 0.01), indicating a polygenic trait. Significantly associated 
SNPs (p <5 x 10−8) were considered as potential index SNPs. SNPs in LD (r2 > 0.2) with 
a more strongly associated SNP within 3000 kb were assigned to the same locus using 
Functional Mapping and Annotation (FUMA) (Watanabe et al., 2017). Overlapping 
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clumps additionally were merged with a second clumping procedure in FUMA merging 
all lead SNPs with r2 = 1 to 238 independent genome-wide significant genomic loci. 
Genotyping, imputation, and quality control were performed as follows: Blood 
samples were genotyped on two arrays, which share nearly all of their content: the 
UKBiLEVE array (N = 49,949) or the UK Biobank Axiom array (N = 438,414). 
Genotyping was conducted by Affymetrix and was distributed across 33 different 
batches of approximately 4,700 samples. UK Biobank provides extensive information on 
sample processing on its web site, biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=155583. 
UK Biobank performed stringent quality control on the genotyping data at the Wellcome 
Trust Centre for Human Genetics (biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=155580). 
Prior to imputation, all variant sites with a call rate below 90% were filtered out. 
Imputation was carried out by UK Biobank using a merged UK10K-1000 Genomes 
Phase 3 reference panel and the Haplotype Reference Consortium (HRC) panel 
(Bycroft et al., 2018; McCarthy, 2016). UK Biobank preferentially retained SNPs 
imputed to HRC for SNPs present in both imputation panels. Imputation was conducted 
using the IMPUTE4 program.  
Furthermore, we excluded non-European participants identified by k-means 
clustering (k = 4) on the first two principal components derived from the genotype data, 
and we excluded related individuals (KING relatedness metric >0.088, equivalent to a 
relatedness value of 0.25). SNPs were excluded if they had a minor allele frequency 
smaller than 1%, if no call was made in more than 2% of samples following imputation, 
if they were imputed with low confidence (INFO <0.8), if they deviated substantially from 
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Hardy-Weinberg equilibrium (HWE test, p <10-7), or if they were not genotyped and not 
part of the HRC reference panel (McCarthy, 2016).  
A measure of specificity was computed for each gene in each cell-type by 
dividing the expression of a gene in a given cell-type by the total expression of the gene 
in all cell-types (range of specificity: 0-1) (Figure 4E). For each cell-type, we then 
binned the specificity measure into 41 bins (0 representing a gene not expressed in the 
tissue/cell-type, 1 genes in the bottom 2.5% quantile of specificity, 40 genes that are in 
the 97.5% to 100% most specific genes in the tissue/cell-type). We then used MAGMA 
to test for a positive correlation between binned tissue specificity and gene-level genetic 
association with BMI for each cell-type. The gene-level genetic association was 
computed with MAGMA (v1.06) using a window surrounding the gene by 35kb upstream 
to 10kb downstream of the gene. The gene-level association is computed by summing 
the association p-value of SNPs located in the gene windows taking into account the LD 
structure of the region. MAGMA also takes into account confounders such as gene 
length and gene-gene correlation. 
Nts∷gRNA SaCas9 AAV Construct Design, Cloning, and Surgery 
 Exons conserved across in all known Nts isoforms were selected and used as 
input for gRNA section. CRISPOR (http://crispor.tefor.net/) (Haeussler et al., 2016) was 
used to identify PAM sites and guide sequences. A guide targeting exon 3 just upstream 
of the NTS neuropeptide coding domain was chosen based on CRISPOR specificity 
score and predicted translation products. A pair of complementary oligonucleotides 
encoding the gRNA against the selected locus (Nts∷gRNA) (Integrated DNA 
Technologies, Coralville, IA) was phosphorylated with T4 polynucleotide kinase in T4 
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DNA ligase buffer (New England Biolabs, Ipswich, MA) at 37ºC for 30 minutes and 
passively cooled to room temperature to anneal. The insert was cloned upstream of a 
U6 promoter into an AAV construct expressing Staphylococcus aureus Cas9 (SaCas9) 
under the control of Cre (Figure 9D). The construct was designed by Avery Hunker 
(Hunker et al., 2020) and provided by Larry Zweifel (University of Washington), modified 
from (Ran et al., 2015). Virus containing the expression construct was packaged at the 
University of North Carolina at Chapel Hill Viral Vector Core. For surgery, Vglut2-Cre (n 
= 10, 5 male) and wild-type littermates (n = 10, 5 male) aged 2-6 months were injected 
bilaterally with 500 nL of AAV5-DIO-Nts-Cas9 targeting the LHA. Following surgery, 
mice were singly housed and maintained on ad lib. standard chow for 3 weeks while 
food intake and body weight were monitored. Mice were then switched to ad lib. HFD for 
10 weeks while food intake and body weight were measured.  
Body Composition and Temperature 
 Water, fat, and lean mass were measured using an EchoMRI™-100H magnetic 
resonance imaging system (Echo Medical Systems, Houston, TX) at the University of 
North Carolina at Chapel Hill Animal Metabolic Phenotyping Core (Figure 9K-M). Mice 
were placed in a specially sized, clear ventilated plastic restrainer with a 2-inch diameter 
without sedation or anesthesia. The tube was then inserted into the lumen of the 
EchoMRI™ system for approximately 2 minutes for scanning (Davis et al., 2019). For 
body temperature, mice were manually scruffed and temperature was measured at the 
perineum during the dark cycle using a non-contact infrared veterinary thermometer 




Figure 1. Droplet-based single-cell RNA-sequencing workflow. A. Generalized 
schematic of single-cell RNA-sequencing workflows. Live tissue of interest is first 
isolated and single-cell suspensions are prepared by enzymatic and mechanical 
dissociation. Individual cells are partitioned into oil emulsions with barcoded 
oligonucleotide-coated microparticles (i.e. agarose beads) using either a commercial or 
custom-fabricated microfluidic device. Microparticles containing immobilized 
polyadenylated transcripts from individual cells are pooled and purified for solid-phase 
reverse transcription, amplified, and prepared for next-generation sequencing, after 
which transcripts are mapped to a reference genome and counted. B. Generalized 
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diagram of RNA-capture microparticle used in droplet-based single-cell RNA-
sequencing protocols. Microparticles are coated in oligonucleotides that terminate in a 
stretch of poly(dT). Oligonucleotides share a common barcode sequence specific to 
each microparticle. Each oligonucleotide contains a specific UMI sequence to allow for 
counting of individual molecules. A common handle sequence is shared amongst all 
oligonucleotides to allow for PCR of microparticle pools. C. Generalized paired-end 
sequencing approach. Paired reads are generated from the barcode region and gene 







Figure 2. LHA Drop-Seq library quality metrics. A. Body weight increased following 
chronic HFD (***p<0.001). Error bars in s.e.m. B. Distribution of genes and transcripts per 
cell. A median of 619 unique genes and 961 unique transcripts were detected in the final 
filtered dataset. C. Pearson correlations before and after batch correction. m1-m7 denote 
individual mice. D. Relative log expression collapses to zero following batch correction. 
 41 
E. Cells plotted in t-SNE space following batch correction. Each color corresponds to a 
unique mouse. F. The number of unique genes detected varied as a function of number 
of UMIs similarly across all clusters (left). The number of genes detected per cluster was 
independent of cluster size (right). G. Percent mitochondrial genes detected across all 
clusters in the final filtered dataset. H. Number of UMIs detected across all clusters in the 








Figure 3. Transcriptional profiling of LHA cells following chronic HFD exposure. 
A. Schematic of experimental pipeline (n=7 control mice, 10,086 cells; n=7 HFD mice, 
10,108 cells). Scale bar, 1 mm. B. t-SNE visualization of 20,194 total cells. Control and 
HFD cells were clustered together. C. t-SNE visualization of 14 transcriptionally distinct 
clusters. Canonical markers identifies resident cell-types in LHA tissue. D. Statistically 
defined clusters exhibit distinct expression patterns. Scale bar, 500 genes. E. Four 
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clusters represent known LHA neuronal populations. F. Fluorescence in situ 
hybridization (FISH) of Vgat and Vglut2. Scale bar, 50 µm. The proportion of cells 
expressing Vgat, Vglut2, or both Vgat and Vglut2 is similar for sequencing (Seq) and 
FISH. Astro, astrocytes; Endo, endothelial; EOC, extraosseous osteopontin-expressing 
cells; Mch, melanin-concentrating hormone; MG, microglia; Olig, oligodendrocytes; 
OPC, oligodendrocyte precursor cells; Orx, orexin/hypocretin; Peri, pericytes; VSM, 





Figure 4. HFD alters the transcriptional profile of LHAVglut2 neurons. A. Signal-to-
noise ratio (SNR) of significantly altered genes (p≤0.001) within each cluster. Outliers 
with SNR>2 are clipped for display. B. Percent of total genes significantly altered 
(p≤0.0001) in ≥50% of cells per cluster. C. Empirical cumulative distribution of p-values 
(p≤0.1) within neuronal clusters for DEGs detected in ≥50% of cells by cluster. * 
p<0.0001 via K-S test. D. p-values vs. asinh fold-change for all genes within the Vglut2 
cluster. E. Gene-level genetic association with human BMI across clusters. Dashed line, 
Bonferroni significance threshold. F. Cell-state trajectories across control and HFD cells. 
G. HFD cells are enriched at later pseudotimes (top) and DEGs show pseudotime-
dependent expression patterns (bottom, abridged from Figure S4). H. DEGs (p≤0.001) 
were queried against multiple annotation databases revealing altered expression in 
activity-dynamic-associated functional classes (see Methods). I-K Chronic HFD 
suppresses LHAVglut2 activity. I. Schematic of longitudinal two-photon calcium imaging 
experimental design. J. Example of individual neurons that were tracked during obesity 
(s.d. projections). K. Average response of LHAVglut2 neurons to sucrose consumption 
during obesity. 0 weeks: 232 neurons from 6 control mice, 220 neurons from 7 HFD 
mice; 2 weeks: 188 neurons from 6 control mice, 231 neurons from 7 HFD mice; 12 
weeks: 105 neurons from 4 control mice, 201 neurons from 7 HFD mice. Data in panels 
I-K was generated and analyzed by Mark Rossi, Ph.D. For experimental methods used 




Figure 5. Genes comprising annotation classes altered in LHAVglut2 neurons 
demonstrate pseudotime-dependent expression patterns. A. Cells (columns) are 
arranged by pseudotime. Dots (left) represent gene-wise membership in select 
annotation classes related to neuronal activity dynamics (Figure 4H). B. Pseudotime-







Figure 6. Distinct subtypes of LHAVglut2 neurons are modified by HFD. A. Reclustered 
glutamatergic neurons plotted in t-SNE space. 15 subclasses of glutamatergic cells 
identified (n = 911 control cells, 1,309 HFD cells). B. Distribution of Vglut2 cells across 
the 15 clusters. C-D. Glutamate clusters express distinct features. E. Pairwise Pearson 
correlation coefficients of the asinhFC values for each cluster. F. Percentage of cells 
within each cluster coming from the HFD group. G. Signal-to-noise ratio (SNR) for each 
gene within each cluster. H. Percentage of genes within each cluster that are significantly 
modified by HFD. 
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Figure 7. Modification of Vglut2 subclasses by HFD and GABA and Glutamate 
receptor expression in glutamate subclasses. A. Subclasses of glutamate neurons 
are differentially modulated by HFD. Each column corresponds to one cluster of Vglut2 
neurons. B. GABA receptor subunit and C. glutamate receptor subunit differential 
expression between HFD and control. Only genes detected in ≥5% of cells within a 
subcluster are included. Positive asinhFC values indicate upregulation in the HFD group, 
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Figure 8. Neuropeptide, transcription factor, and GPCR differential expression in 
glutamate sub-clusters. A. Neuropeptide differential expression (gene list from 
http://www.neuropeptides.nl) (Burbach, 2010). B. Transcription factor differential 
expression (GO:0005667). C. GPCR differential expression. (GO:0004930). Positive 
asinhFC values indicate up-regulation in the HFD group, while negative asinhFC values 
indicate down-regulation in the HFD group. Only genes detected in ≥5% of cells within a 
subcluster are included. Positive asinhFC values indicate up-regulation in the HFD group, 





Figure 9. SaCas9-mediated loss-of-function of Neurotensin in LHAVglut2 neurons 
attenuates HFD-induced weight gain. A. Percent of cells by subcluster in which Nts 
was detected. B. Average Nts HFD vs control asinhFC in glutamatergic subclusters in 
which Nts was detected in ≥ 5% of cells. C. t-SNE detail showing relative Nts fold-change 
in the two subclusters containing the highest absolute asinhFC. D. Upper, viral strategy 
for Cre-dependent SaCas9-mediated mutation of Nts. Nts∷gRNA and SaCas9 are 
expressed by the same construct and SaCas9 expression is under the control of Cre 
(Hunker et al., 2020). Middle, schematic of the Nts locus. The PAM site is located just 
upstream of the Nts peptide coding region (NT) in the third exon. Bottom, the predicted 
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SaCas9-mediated mutation will result in a frameshift and early termination of the 
translation product upstream of the neuropeptide coding domain. E. Schematic depicting 
bilateral injection sites of AAV expressing Nts∷gRNA and SaCas9. F. SaCas9-mediated 
mutation of Nts significantly attenuates HFD-induced cumulative weight gain in Vglut2-
Cre+ mice but not Cre- controls. BL, pre-surgery baseline chow intake. G. SaCas9-
mediated mutation of Nts significantly attenuates HFD-induced maximum weight gain in 
Vglut2-Cre+ mice but not Cre- controls. H. SaCas9-mediated mutation of Nts significantly 
attenuates HFD-induced cumulative food intake in Vglut2-Cre+ mice but not Cre- controls. 
BL, pre-surgery baseline chow intake. I. SaCas9-mediated mutation of Nts significantly 
attenuates HFD-induced daily caloric intake in Vglut2-Cre+ mice but not Cre- controls. F-I 
Statistical tests are two-way repeated measures ANOVA. *p<0.05. Vglut2-Cre-, n = 10; 
Vglut2-Cre+, n = 8. J. SaCas9-mediated mutation of Nts does not significantly modify 
basal body temperature in Vglut2-Cre+ or Cre- controls. K. SaCas9-mediated mutation of 
Nts does not significantly modify body water mass in Vglut2-Cre+ or Cre- controls. L. 
SaCas9-mediated mutation of Nts does not significantly modify body fat mass in Vglut2-
Cre+ or Cre- controls. M. SaCas9-mediated mutation of Nts does not significantly modify 








CHAPTER 4. CELL-TYPE-SPECIFIC TRANSCRIPTIONAL KINETICS INFORM 
ALLOSTATIC TRAJECTORIES IN OPIATE WITHDRAWAL 
Introduction 
 In each year between 2017-2019, approximately 70,000 Americans died by drug 
overdose (Hedegaard et al., 2018), resulting in an overall reduction in life expectancy in 
the United States (Woolf and Schoomaker, 2019). The majority of these drug overdose 
deaths have been associated with opioids and opiates and are generally considered to 
be undercounted (Boslett, 2020; Kariisa, 2019; Seth, 2018). As such, understanding the 
factors leading to opioid and opiate5 dependence is a critical public health demand. 
 In addiction, persistent drug use is thought to be motivated by a combination of 
compulsive seeking of the rewarding effects of a drug and continued avoidance of the 
unpleasant feelings associated with abstinence (Koob and Le Moal, 1997, 2005). In 
both humans and experimental animals, spontaneous termination of opiate use in 
dependent individuals produces a complex of negative physical and emotional features 
that broadly result from increased sympathetic nervous outflow and affective 
dysregulation. During withdrawal, these features arise and occur across multiple time 
courses (Gold et al., 1978; Schuckit, 2016) and may be re-experienced long after the 
cessation of use upon the presentation of drug-associated cues (Goldberg and 
Schuster, 1970; O’Brien, 1975, 1977; Wikler, 1948; Wikler and Pescor, 1967). As such, 
continued use and relapse in opiate-dependent individuals are thought to be primarily 
                                               
5 For simplicity, both the opioid and opiate classes of drugs will be generalized as “opiate” unless otherwise specified. 
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motivated by a desire to avoid the severe negative symptoms of opiate withdrawal 
syndrome. 
 The nucleus accumbens (NAc) is a critical brain region involved in the processing 
of motivated drug seeking, reward, reinforcement, and aversion. Excitatory 
glutamatergic inputs to the NAc from multiple cortical and subcortical regions encode 
reward-associated environmental cues, and these inputs are integrated with reinforcing 
dopaminergic signals from the midbrain to coordinate motivated reward seeking (Britt et 
al., 2012; Ikemoto, 2007; Ikemoto and Bonci, 2014; Phillips et al., 2003; Stuber et al., 
2011). In addition to facilitating motivated reward seeking, the NAc also serves as a 
substrate for salient aversive stimuli, and anatomically-defined regions within the NAc 
uniquely encode both rewarding and aversive cues (Castro and Bruchas, 2019; Jensen 
et al., 2003; Lim et al., 2012; Reynolds and Berridge, 2002; Roitman et al., 2005, 2008; 
Soares-Cunha et al., 2019).  
 Consistently, the NAc functions as a major site in the representation and 
computation of drug reward- and withdrawal-associated experiences, and in the 
coordination of contextually-appropriate action-outputs. As such, it is critically involved 
in the evolution of opiate dependence (Harris and Aston-Jones, 1994; Koob, 1989; Zhu 
et al., 2016). Although glutamatergic afferents into the NAc are generally thought to 
primarily encode reward cue-associated signals, glutamatergic transmission from the 
medial thalamus to the NAc has been shown to mediate aversion during naloxone-
precipitated morphine withdrawal (Zhu et al., 2016), and medial thalamic sites have 
been broadly shown to be involved in drug-seeking behavior (Browning et al., 2014). 
 56 
 Chronic drug use produces long-term cell-state changes in the neurocircuit 
elements that mediate reward and aversion as a result of drug- and activity-induced 
signaling through gene regulatory mechanisms (Nestler, 2001; Robison and Nestler, 
2011; Sun et al., 2012). As such, protracted withdrawal syndromes may be appreciated 
in part by understanding the events and time course of transcriptional allostasis within 
the neurocircuit substrates that govern and display rewarding and aversive features of 
opiate seeking and withdrawal. Here, we perform high-throughput single-cell RNA-
sequencing of the NAc and medial thalamic complex (MTC) during spontaneous 
withdrawal following a chronic escalating morphine regimen in mice. We first identify 
canonical transcriptional features marking discrete resident tissue cell-type populations 
within the NAc and MTC and show that NAc cell-types are uniquely sensitive to chronic 
morphine exposure. By profiling cells across different withdrawal time points, we then 
characterize time course-dependent changes in morphine withdrawal and show that 
NAc and MTC cell-types exhibit distinct patterns of differential gene expression across 
time. Within the NAc, we identify a unique subtype of Dopamine Receptor D1-
expressing (Drd1) neurons and classify time course-dependent kinetics of gene 
expression within this population. By applying contemporary experimental and analytical 
approaches, these findings describe how two anatomically- and molecularly-distinct 
brain substrates involved in the representation and expression of opiate experiences 
are uniquely sculpted by chronic opiate exposure and termination. When generalized, 
our findings suggest that changes in cell-state to an allostatic pressure are highly-
dependent on cell-type characteristics as well as to the functional relationship of these 
cell-types to the specific biological pressures presented. 
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Results 
A Transcriptional Atlas of Accumbal and Medial Thalamic Cell-Types 
 In order to characterize cell-type-specific kinetics of gene expression during 
spontaneous opiate withdrawal, we processed male wildtype mice though an escalating 
morphine regimen and examined transcriptional effects at multiple time points following 
the cession of morphine administration (Figure 10A). We collected tissue from the NAc 
(Figure 10B) and MTC (Figure 10C) and used high-throughput droplet-based single-
cell RNA-sequencing (Kim et al., 2019; Moffitt et al., 2018; Sharma et al., 2020) (Figure 
1) to transcriptionally profile cells from animals sacrificed 12 hours, 24 hours, and 48 
hours after their final morphine dose, as well as from a control group receiving a similar 
saline regimen. A total of 56,226 cells in the NAc (Figure 11A) and 49,070 cells in the 
MTC (Figure 11B) were sequenced to a median of approximately 2,300 unique genes 
per region (Figure 11J). Cells from the control and all withdrawal time point groups 
were integrated using the control and 12-hour time point as reference anchors (Stuart et 
al., 2019) and the cells were subsequently clustered on principal components calculated 
on the expression of high variance genes across the dataset (Figure 11A-D). In order to 
allow for the visualization of cell-type trajectory structure in the underlying data, cells 
were embedded in UMAP space (Figure 12A-D). Resident NAc and MTC tissue cell-
types including neurons, glia, and stromal cells were identified by the expression of 
canonical marker features (Figure 12E) and were consistent with previous single-cell 
RNA-seq characterization of these regions (Avey et al., 2018; Phillips et al., 2019). 
Across the neuronal cluster, cell density and distribution in UMAP space suggested the 
presence of underlying molecularly-defined distinct neuronal subtypes (Figure 12A-B). 
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Prioritization of Transcriptional Allostasis Across Cell-Types  
During Morphine Withdrawal 
 Opiate withdrawal induces distinct patterns of activation across brain regions and 
results in time course-dependent changes in withdrawal symptoms, behavior, and gene 
expression (Balter and Dykstra, 2013; Fukunaga et al., 1998; Georges et al., 2000; 
Hayward et al., 1990; Robison and Nestler, 2011; Zhu et al., 2016). We therefore 
sought to explore cell-type-specific patterns of transcriptional alteration across the time 
course of withdrawal (Figure 13). We did not observe any new clusters of 
transcriptionally-defined cell-types that emerged in morphine-treated animals (Figure 
13A), supporting the validity of statistical alignment and integration. Within each cluster, 
we examined the fraction of genes that were significantly differentially-expressed 
between each withdrawal time point and the control cells. We observed a high 
proportion of genes that are differentially-expressed in at least one or all of the time 
points amongst both astrocytes and neurons in both the NAc and MTC (Figure 13B-C). 
In general, we observed a higher fraction of genes that were differentially-expressed in 
morphine withdrawal across all stromal, glial, and neuronal classes in the NAc as 
compared to the MTC (Figure 13B). Within the astrocyte and neuronal clusters, we 
found a higher fraction of genes that were persistently differentially-expressed from 12 
to 48 hours after the final morphine dose in the NAc as compared to the MTC (Figure 
13C), suggesting that transcriptional perturbations to morphine and withdrawal in NAc 
neuronal and astrocyte populations are more long-lasting than those observed in the 
corresponding MTC cell-types. 
 We further sought to characterize how morphine and withdrawal shift 
transcriptional states across cell-types in the NAc and MTC in an unsupervised manner. 
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To do so, we trained a classifier on a subset of cells by cluster within each individual 
time point as compared to the control. We then used the trained classifier to iteratively 
predict from which each time point group each sample of cells originated (Skinnider et 
al., 2019). Classification accuracy for each time point by cluster was used as a measure 
of transcriptional divergence from the control state (Figure 13D). As reflected by the 
fraction of genes significantly differentially-expressed by cluster (Figure 13B), we found 
that NAc classification accuracy was higher than in the MTC, both across all cell-types 
and across all withdrawal time points (Figure 13D-E), suggesting that NAc cell-types 
are more drastically modified by chronic morphine and withdrawal. Consistent with our 
previous observations (Figure 13C), we observed the highest classification accuracy at 
later time points in NAc neurons as compared to MTC neurons (Figure 13E), supporting 
the hypothesis that MTC neurons are more transiently perturbed in withdrawal. 
Transcriptional Kinetics of Morphine Withdrawal Within  
Accumbal Neuronal Subtypes  
 Considering our observation that neurons in the NAc exhibit a high degree of 
persistent transcriptional perturbation relative to other cell-types in both the NAc and 
MTC, we sought to further characterize how neuronal subpopulations in the NAc were 
altered by chronic morphine and withdrawal (Figure 14). We isolated the neurons in the 
NAc dataset and reclustered them in UMAP space (Figure 14A) without anchoring and 
realigning the cells, allowing for the observation of biologically-meaningful trajectories 
across time point groups (Figure 14B). As expected, we identified populations of 
medium spiny neurons expressing either the D1 (Drd1) or D2 (Drd2) dopamine 
receptors (Castro and Bruchas, 2019; Soares-Cunha et al., 2019) (Figure 14C). Within 
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D1 medium spiny neurons, we identified a novel subset of neurons expressing the gene 
CAMP-Dependent Protein Kinase Inhibitor Beta (Pkib) (Figure 14C, inset).  
 We examined the distribution of cells within the Pkib subcluster in UMAP space 
and found that Pkib-expressing NAc neurons displayed a distinct trajectory, with control 
cells clustered opposite of branching populations of cells from each withdrawal time 
point (Figure 14D). We designated the control cells within this cluster as the root state 
and constructed a learned cell-state trajectory to assign pseudotimes values to each cell 
(Cao et al., 2017; Qiu et al., 2017; Trapnell et al., 2014) (Figure 14E). Within this 
population, we found that cells were not strictly ordered according to withdrawal time 
point, and instead found that cells at the 12- and 48-hour time points were ordered at 
the end of the pseudotime trajectory with the 24-hour withdrawal time point ordered 
near the control cells (Figure 14F). This finding was consistent with the trained classifier 
prediction accuracies observed across all NAc neurons (Figure 13D), suggesting that 
the 24-hour time point represents a deflection towards the control state in NAc neurons. 
 To further characterize the effect of morphine withdrawal on transcriptional states 
across time, we examined the pseudotemporal kinetics of specific gene groups within 
the Pkib-expressing NAc subpopulation. Using an unsupervised clustering approach 
similar to that applied for the clustering of cells (Figure 14A), we grouped genes based 
on their expression across pseudotime. Using this approach, we identified modules of 
genes that followed similar patterns of co-expression across morphine withdrawal time 
points (Figure 14G-H). We further grouped these modules using k-means clustering 
and observed 6 distinct pseudotemporal kinetics across the data. Given this, we 
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hypothesize that genes exhibiting similar kinetics may be under common regulatory 
control mechanisms, but this has not yet been explored. 
Discussion 
 Glutamatergic inputs to the NAc from cortical and limbic regions encode reward- 
and aversion-associated cues, where they are integrated with reinforcing signals from 
dopaminergic midbrain projections to orchestrate motivated reward seeking or aversion 
(Al-Hasani et al., 2015; Britt et al., 2012; Ikemoto, 2007; Ikemoto and Bonci, 2014; Lim 
et al., 2012; Phillips et al., 2003; Roitman et al., 2008; Stuber et al., 2011). Canonically, 
these inputs synapse onto GABAergic medium spiny neurons that express either the D1 
or D2 Dopamine Receptors to communicate positive and negative valence signals, 
respectively (Castro and Besrridge, 2014; Hikida et al., 2010; Kravitz et al., 2012). 
However, a wide variety of neuropeptide and receptor systems have been shown to be 
expressed within the NAc, but how these features are distributed amongst D1 and D2 
medium spiny neurons has not been described.  
 To this end, we classify subtypes of neurons in the NAc (Figure 14A) and 
identify a novel subpopulation of Drd1-expressing neurons that is robustly labeled by 
the cyclic AMP (cAMP) modulator Pkib. (Figure 14C). We demonstrate that this NAc D1 
subpopulation exhibits unique patterns of transcriptional modification over the time 
course of withdrawal and identify gene groups that follow similar pseudotemporal 
kinetics across withdrawal time (Figure 14G-H). Further understanding the factors 
regulating gene-wise transcriptional patterns during withdrawal is expected to extend 
our understanding of the cell-type-specific changes in cell-state that occur during opiate 
dependence and may aid in the identification of targets for therapeutic intervention.
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 Although both the NAc and MTC broadly express the μ-opioid receptor and are 
both involved in regulating opiate- and withdrawal-associated reward and aversion, it is 
unclear how these two systems are independently shaped by chronic opiate use 
(Brunton and Charpak, 1998; Corre et al., 2018; Harris and Aston-Jones, 1994; Hearing 
et al., 2016; Koob, 1989; McDevitt and Graziane, 2019). By examining cells collected 
from multiple withdrawal time points, we characterize time course-dependent changes 
in morphine withdrawal and show that NAc and MTC cell-types exhibit distinct patterns 
of differential gene expression across time. Consistently, within the NAc, we find that 
neurons display longer-lasting patterns of transcriptional modification to chronic 
morphine than neurons in the MTC (Figure 13B-D). Unlike the MTC, the neuronal 
populations on the NAc are susceptible to both the direct influence of morphine on cell 
surface μ-opioid receptors, as well as the influence of midbrain dopamine inputs that 
robustly communicate opiate-associated reward. Given the involvement of both 
dopamine receptor and μ-opioid receptor systems in modulating cytosolic cAMP 
accumulation, as well as the importance of cAMP in regulating downstream gene 
expression events, it is possible that NAc populations receive greater allostatic 
pressures than the MTC during chronic morphine exposure. Further studies exploring 
the in vivo activity dynamics of neuronal populations in both regions during withdrawal 
are required to further understand the influence of chronic opiate use on cell-state 
changes in these substrates. To our knowledge, the findings and approaches presented 
here represent the first cellular-resolution characterization of drug-induced 




Animals and Morphine Administration 
 Male C57BL/6J mice were acquired from The Jackson Laboratory (Bar Harbor, 
Maine) and housed for 10 days prior to pharmacological manipulation. At age p52±1, 
mice received intraperitoneal injections of either 0.9% sterile saline or morphine sulfate 
(NIH NIDA drug supply program). Doses from 10-70 mg/kg morphine were used, with 
doses escalating in increments of 10 mg/kg each day (day 1, 10 mg/kg; day 7, 70 
mg/kg) (Figure 10A). Each dose was administered twice daily between 60-120 minutes 
after the start of each light/dark cycle. Saline and morphine were administered in a 
volume of 10 μL/g bodyweight and morphine doses were dissolved in 0.9% sterile 
saline. Animals for each sample were group-housed and maintained on a 12/12-hour 
light/dark cycle under standard conditions. All mice were handled twice daily for 3 days 
preceding pharmacological manipulation. Mice were not handled during the withdrawal 
interval following the final dose in the protocol. Mice were transferred out of the animal 
facility and housed within an animal cabinet in the laboratory for habituation 12 hours 
prior to tissue collection. 
Tissue Isolation and Single-Cell RNA-sequencing 
 Tissue from 4 group-housed mice receiving similar pharmacological manipulation 
and withdrawal time points was pooled per sample. Each sample was comprised of one 
brain region (either NAc or MTC), and only one region was collected per group of mice. 
Mice were deeply anesthetized with 390 g/kg sodium pentobarbital, 500 mg/kg 
phenytoin sodium and rapidly transcardially perfused with 20 mL ice-cold sodium-
substituted aCSF (NMDG-aCSF) containing 96 mM N-methyl-D-glucamine (NMDG), 2.5 
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mM KCl, 1.35 mM NaH2PO4, 30 mM NaHCO3, 20 mM HEPES, 25 mM glucose, 2 mM 
thiourea, 5 mM Na+ascorbate, 3 mM Na+pyruvate, 0.6 mM glutathione-ethyl-ester, 2 mM 
N-acetyl-cysteine, 0.5 mM CaCl2, 10 mM MgSO4, and adjusted to pH 7.35–7.40, 300-
305 mOsm (Rossi et al., 2019; Ting et al., 2014). Brains were isolated and 280 μm 
sections through the NAc (4sections) and MTC (7 sections) were collected in ice-cold 
NMDG-aCSF on a Leica VT1200 vibratome. Sections were recovered in ice-cold 
carbogen-buffered NMDG-aCSF containing 500 nM TTX, 10 μM APV, 10 μM DNQX, 5 
μM actinomycin D, 22.5 μM anisomycin (NMDG-aCSF-R) for 30 minutes to reduce 
excitotoxicity and dissociation-induced transcriptional activity (Hrvatin et al., 2018; Wu et 
al., 2017). After recovery, tissue was manually isolated under a stereomicroscope using 
an ophthalmic microscalpel (Figure 10B and 10C) and incubated in ice-cold NMDG-
aCSF-R containing 1.0 mg/mL pronase for 60 minutes passively ramping to room 
temperature. Following enzymatic digestion, tissue was transferred to 1.0 mL NMDG-
aCSF-R supplemented with 0.05% fatty acid-free bovine serum albumen (NMDG-aCSF-
BSA) and mechanically dissociated with a borosilicate patch pipet fire-polished to an 
internal diameter of 200-300 μm. The suspension was washed in 13 mL NMDG-aCSF-
BSA, filtered through a 40 μM strainer, sedimented at 220 x g for 6 minutes at 4ºC, and 
resuspended in 100 μL (NAc) or 200 μL (MTC) dead-cell removal magnetic bead 
solution (Miltenyi Biotec, Bergisch Gladbach, Germany) for 15 minutes at room 
temperature (Hashikawa et al., 2020; Kinoshita et al., 2002). The bead/cell mixture was 
resuspended in a total volume of 2 mL of binding buffer, applied to an equilibrated 
binding column, and washed with 2 mL of binding buffer. The eluate containing cells 
was collected sedimented at 220 x g for 6 minutes at 4ºC and resuspended in a volume 
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of 100 μL sterile PBS containing 0.05% nuclease-free, non-acetylated bovine serum 
albumen on ice. Cells were manually counted on a Fuchs-Rosenthal hemocytometer 
and the volume was adjusted to a final concentration of 800-1100 cells/μL. 
 Single-cell RNA-sequencing was performed using Chromium Single Cell 3' v3 
chemistry (10X Genomics, Pleasanton, CA) following manufacturer recommendations 
unless otherwise denoted. Approximately 18,000-20,000 cells were loaded into an 
individual Single Cell B Chip per sample. Each sample (brain region and time point) was 
run on a separate chip on a separate day. cDNA amplification was performed with 11 
cycles. Sample indexing was performed with 10-12 cycles dependent on sample cDNA 
yield. Library species distribution and concentrations were determined with an Agilent 
4200 Tapestation High Sensitivity D5000 ScreenTape and a Thermo Scientific Qubit 
dsDNA HS Assay, respectively. Next generation sequencing was performed using the 
standard 10X Genomics paired-end configuration on an Illumina NovaSeq 6000 using 
2x100 S4 chemistry by Genewiz, Inc. (South Plainfield, NJ). Four samples were pooled 
per lane. Each sample was sequenced to between 580-875 million reads with a mean 
quality score >30.60 for all samples. A mean of 26,121 reads/cell and 30,556 reads/cell 
were sequenced in the NAc and MTC, respectively (Figure 11H).  
Single-Cell RNA-Sequencing Clustering and Analysis 
 Demultiplexing was performed with 1 mismatch allowed using Illumina bcl2fastq 
v2.18.0.12. Initial processing of reads and generation of digital expression matrices was 
performed using 10X Genomics Cell Ranger v3.1.0 with 128 GB of memory on 24 cores 
for alignment. Sequences were aligned to the mm10 3.0.0 reference genome. Read 
counting was performed with SAMtools v1.10 (Li et al., 2009). 
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 Clustering was performed using a combination of Seurat v3.1.2 (Stuart et al., 
2019) and custom code in R v3.6.1 unless otherwise noted. In the language below, 
“group” denotes a brain region and “sample” denotes an individual control or withdrawal 
time point. For clustering of all cells, cells in which < 1000 unique genes, > 2 s.d from 
the mean individual transcripts, and ≥ 15 percent mitochondrial reads were detected 
were filtered from each group dataset (Figure 11). Only genes that were detected in all 
samples within a group were included in downstream analyses. Doublets were detected 
separately within each sample and removed using DoubletDetection v2.5.4 (Gayoso 
and Shor, 2019) on Python 3.7 run in R v3.6.1 via Reticulate v1.14 (Figure 11E-F). The 
first 50 dimensions were used in the doublet classifier with the number of iterations set 
to the number of cells in the sample/100. A voter threshold of 0.5 and p-value threshold 
of 1-16 were used in the classification stringency. Following count-based filtering and 
doublet removal, 56,226 cells in the NAc group and 49,070 cells in the MTC group were 
retained with a median of 2,335/4,840 and 2,312/4,857 unique genes/transcripts 
detected in each group, respectively (Figure 11I-K). 
 Filtered data was transformed using a regularized negative binomial regression 
via SCTransform (Hafemeister and Satija, 2019; Stuart et al., 2019) with percent 
mitochondrial reads and number of unique transcripts used as latent variables. Variable 
genes accounting for 20% of all genes in each group dataset were used as input. 
Samples from each sample within a group were integrated using canonical correlation 
analysis reduction (Butler et al., 2018; Stuart et al., 2019) using the control and 12 hour 
withdrawal time point samples as references (Figure 11A-D). All genes in each group 
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were used as anchor features. Pearson residuals from the regularized negative binomial 
regression and integration were calculated for all genes in a group. 
 Principal components were calculated on all genes in each group dataset, and 
the first components explaining ~99.85% of the total variance of the log-transformed 
corrected counts were used as input for UMAP embedding (McInnes et al., 2018) 
(Figure 12). For the NAc group, UMAP was performed on 69 principal components with 
50 neighbors, a minimum distance of 0.60, and a spread of 0.40. For the MTC group, 
UMAP was performed on 72 principal components with 40 neighbors, a minimum 
distance of 0.50, and a spread of 0.50. UMAP epochs were scaled according to the 
number of cells in each dataset. For clustering, a k-nearest neighbor graph was 
constructed across cells in each group and used as input to construct a shared nearest 
neighbor graph by calculating the Jaccard index between every cell and its 20 nearest 
neighbors using on the same principal components used for UMAP embedding in each 
dataset. Clustering was performed using the Louvain algorithm with multilevel 
refinement (Rodriguez and Laio, 2014; Rotta and Noack, 2011; Šubelj and Bajec, 2011) 
with a resolution of 0.01 (Figure 12A-B). Clusters were reordered based on a 
dendrogram estimated on a hierarchically-clustered distance matrix constructed on all 
genes in each group dataset. For the NAc group, two neuronal clusters were merged to 
create one large cluster comprising all neurons. 
 Feature discovery was performed on the Pearson residuals from the regularized 
negative binomial regression using a likelihood-ratio test for single-cell data as 
implemented in Seurat (Hafemeister and Satija, 2019; Macosko et al., 2015; McDavid et 
al., 2013). For cluster features, all genes in each cluster were tested against those in 
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either the nearest cluster or node in the dendrogram tree (Figure 12E). For group 
features, intra-cluster group comparisons were performed using the same test by 
comparing residuals in each morphine withdrawal time point sample to the control 
sample for all genes in each group (Figure 13B-C). 
 Comparisons of gene expression levels between groups were performed on 
inverse hyperbolic sine (asinh) transformed data (Amir et al., 2013; Hoffman et al., 
2012; Rossi et al., 2019). 
 For gene x;  
 asinh fold-change (asinhFC) was defined as: 
   "#$%ℎ'( = 	+%,⟨./0⟩ + 3⟨./0⟩4	 + 16 − +%,⟨.8⟩ +	3⟨.8⟩4 	+ 16	 
where M t denotes expression in a morphine withdrawal time point sample,  
and C denotes control sample expression. 
 Prepossessing, alignment, generation of digital expression matrices, regularized 
negative binomial regression, sample integration, dimensionality reduction, clustering, 
and feature discovery using the likelihood-ratio test for single-cell data were run on a 
Dell blade-based cluster running Linux RedHat Enterprise 7.7. All other steps were 
performed on an Apple MacBook Pro running macOS 10.15.3. 
Cell-type prioritization and Pseudotime Analysis 
 Cell-type prioritization was performed using Augur v1.0.0 (Skinnider et al., 2019) 
using 8 threads (Figure 13D-E). Briefly, augur was used to train a classifier on a subset 
of cells under each categorical label and then predict the correct sample label for 
withheld cells. Cell-type differences between groups were identified based on the 
iterative classification accuracy from the area under the receiver operating characteristic 
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curve (AUC). For each group, each sample within a cluster was compared to the control 
sample. A random forest classifier was used for classification with 3-fold cross-
validation. Clusters were ranked based on mid-extreme AUC values (Figure 13E). 
Within each cell-type, AUC values were used to assess divergence from the control 
state across time point samples in a group. 
 Pseudotime analysis on NAc neurons was performed using Monocle3 v0.2.1 
(Cao et al., 2019; Qiu et al., 2017; Trapnell et al., 2014) (Figure 14). The neuronal 
cluster was isolated and preprocessed using default parameters. 50 principal 
component dimensions were used for UMAP reduction. Unsupervised clustering on 
principal components was performed using the Leiden algorithm (Traag et al., 2019) 
with a resolution of 1-6 (Figure 14A). A principal graph was learned on reduced UMAP 
dimensions and each cell’s projection on the graph was used to arrange cells in order of 
transcriptional similarity and assign pseudotime values (Figure 14E-F). Differentially-
expressed features across pseudotime were identified using Moran’s I test as 
implemented in Monocle3. Genes with I > 0.01 and a q-value < 0.01 were selected for 
downstream analysis. Pseudotemporally co-expressed genes modules were identified 
by clustering on a k-nearest neighbor graph in UMAP space using the Louvain algorithm 
(Levine et al., 2015; Rodriguez and Laio, 2014; Šubelj and Bajec, 2011) (Figure 14G). 
Modules of genes were further clustered via k-means clustering using default 





Figure 10. Single-cell RNA-sequencing of the nucleus accumbens and medial 
thalamic complex following morphine withdrawal. A. Escalating morphine regimen is 
delivered twice daily for 7 days. Animals are sacrificed at the indicated time points and 
brains are processed for single-cell RNA-sequencing. B. Brain sections containing 
nucleus accumbens collected for single-cell RNA-sequencing. Isolated regions denoted 
by dotted lines. C. Brain sections containing medial thalamic complex collected for single-
cell RNA-sequencing. Isolated regions denoted by dotted lines. Reference atlas sections 




Figure 11. Sequencing and quality metrics for single-cell RNA-sequencing of 
nucleus accumbens and medial thalamic complex. A-B. Distribution of cells in time 
point sample groups in UMAP space following filtering, regularized negative binomial 
regression, reference-based alignment, and clustering. A. Nucleus accumbens, 56,226 
total cells. B. Medial thalamic complex, 49,070 total cells. C. Residual mean 
distributions center at zero across genes following regularized negative binomial 
regression. D. Variance of Pearson residuals across genes centers at 1 following 
regularized negative binomial regression. E. Percentage of doublet analytically detected 
across individual samples. F. Percent of doublets detected per 1,000 cells recovered in 
each sample. G. Read frequency per unique molecule across the entire dataset for both 
nucleus accumbens (top) and medial thalamic complex (bottom). H. Total read density 
across cells in the nucleus accumbens (top) and medial thalamic complex (bottom) 
datasets following filtering and doublet removal. Nucleus accumbens, mean 26,121 
reads/cell; medial thalamic complex, mean 30,556 reads/cell. I. Frequency of unique 
transcript UMIs per cell detected in nucleus accumbens (left) and medial thalamic 
complex (right) datasets. Nucleus accumbens, median 4,840; medial thalamic complex, 
median 4,857. J. Frequency of unique genes per cell detected in nucleus accumbens 
(left) and medial thalamic complex (right) datasets. Nucleus accumbens, median 2,335; 
medial thalamic complex, median 2,312. K. Frequency of mitochondrial percentage per 
cell in nucleus accumbens (left) and medial thalamic complex (right) datasets. Nucleus 




Figure 12. Characterization of major resident cell-types in the nucleus accumbens 
and medial thalamic complex. A. Clustering of cells in the nucleus accumbens across 
all time point groups in UMAP space. Cell-types were identified by expression of 
canonical markers distinguishing branches at each node in the cluster tree (inset). B. 
Clustering of cells in the medial thalamic complex across all time point groups in UMAP 
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space. Cell-types were identified by expression of canonical markers distinguishing 
branches at each node in the cluster tree (inset). C. Number of unique genes detected 
per cell across cell-types in the nucleus accumbens (left) and medial thalamic complex 
(right). D. Percentage of cells in dataset within each cluster in the nucleus accumbens 
(left) and medial thalamic complex (right). Total number of cells per cluster is denoted 
above each bar. E. Each cell-type in the nucleus accumbens (left) and medial thalamic 




Figure 13. Morphine withdrawal causes distinct temporal changes in gene 
expression. A. Fraction of cells in each cluster by time point sample groups. B. 
Percentage of all genes that are significantly differentially-expressed in at least one 
(any) or all (all) time points across cell-types in the nucleus accumbens (left) and medial 
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thalamic complex (right). Only genes detected in at least 50 percent of cells in each 
cluster were considered. Cells from each time point were compared to control cells 
within each cluster. Genes with p ≤ 1-4 in the likelihood ratio test for single-cell data were 
considered significant. C. Percentage of genes that are significantly differentially-
expressed within each time point by cluster. Only genes detected in at least 50 percent 
of cells in each cluster were considered. Cells from each time point were compared to 
control cells within each cluster. Genes with p ≤ 1-4 in the likelihood ratio test for single-
cell data were considered significant. D. Area under receiver operating characteristic 
curve from classifier trained on time point groups versus control cells. Clusters within 
the nucleus accumbens (left) and medial thalamic complex (right) are arranged in 
ascending order of their mid-extreme AUC values. E. AUC values for each cell 





Figure 14. Gene expression kinetics in a subtype of neurons in the nucleus 
accumbens. A. Reclustered of neurons in the nucleus accumbens identifies unique 
subtypes of neuronal subpopulations. Subtypes are distinguished by colors, plotted in 
UMAP space. B. Gene expression differences across time points in neuronal subtypes 
is reflected in UMAP trajectories. C. A candidate subpopulation of neurons in the 
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nucleus accumbens expressing the dopamine receptor D1 (Drd1) is specifically labeled 
by cAMP-dependent protein kinase inhibitor-β expression (Pkib, inset). D. Distribution of 
cells from each time point in UMAP space in Pkib-expressing subpopulation. E. Pkib-
expressing subpopulation labeled by pseudotime. Line overlay indicates pseudotime 
trajectory. F. Distribution of cells in Pkib-expressing subpopulation in order of 
pseudotime. G. Normalized expression of gene modules co-expressed across 
pseudotime. Each module (row) is comprised of multiple genes exhibiting similar 
pseudotime-dependent expression dynamics. H. Modules were clustered by similar 
expression patterns across time points. Module clusters are plotted on the same axis. 
Each curve indicates normalized expression of an individual module of genes in cells 
ordered by pseudotime. 
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CHAPTER 5. GENERAL DISCUSSION 
 The concept of allostasis, as borrowed from psychology, differs from 
homeostasis in that it represents a dynamic shift in a system from its baseline state 
rather than an active energetic return to finely-tuned parameter set-points (Fisher and 
Reason, 1988; Sapolsky, 1998; Wingfield, 2003). That is, allostasis requires a persistent 
adjustment in the working boundaries of the affected system in order to maintain 
stability and functionality in the presence of novel pressures. In biology, homeostatic 
versus allostatic pressures can therefore be considered in terms of whether a return to a 
defined homeostatic set-point would be more beneficial to the stability, energy, and 
organization of the system than an overall shift in state to function under a new set of 
parameters as dictated by environmental pressures.  
 The work presented here describes how neural systems transcriptionally respond 
to biologically-relevant pressures, and how those responses are related to the inherent 
characteristics of these systems. Although it would not be possible (nor necessary) to 
define the biology described here explicitly in terms of allostasis versus homeostasis, 
the allostatic model provides a simplified theoretical framework from which to consider 
how transcriptionally-defined cell-states emerge as a response to novel chronic 
perturbations in physiology, as well as to understand how these shifts in cell-state may 
evolve and resolve across time. Hence, the term transcriptional allostasis is applied 
throughout this text to describe the widespread transcriptional changes observed in 
specific cell-types in response to chronic experimental perturbation. Biologically, such 
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changes are mediated through a wide variety of mechanisms that function in concert to 
stably modify gene expression and permit survivability and functionality under these 
new chronic conditions. Such changes occur through both transcriptional events, as well 
events that are not visible in the transcriptome such as epigenomic regulation, post-
transcriptional modification of proteins, and small molecule signaling actions, and the 
downstream effects of cell-cell communication. 
 Obesity, resulting from chronic exposure to a HFD, presents a powerful pressure 
on systemic physiology, with widespread hormonal, immune, and metabolic effects 
(Kahn and Flier, 2000; McLaughlin et al., 2017; Uranga and Keller, 2019). By studying 
the effect of chronic HFD on cell-type-specific transcriptional states in the LHA, we 
found that LHA cellular substrates are broadly but uniquely modified in obesity. We find 
that chronic HFD-induced changes occur in a cell-type-specific manner, with dissociable 
transcriptional representations of obesity state occurring both across broad LHA tissue 
cell-types (Figures 4), as well as amongst neuronal subpopulations (Figures 7-8). We 
leverage differential gene expression and trajectory analysis to identify LHAVglut2 
neurons as an LHA population that is inherently susceptible to HFD manipulation and 
hypothesize that the high degree of transcriptional allostatic load observed in LHAVglut2 
neurons reflects their significance in the regulation of caloric intake (Figures 4-5). By 
examining the functional characteristics of transcriptional features significantly altered 
within this population, we predict and validate changes in the natural activity dynamics 
expressed by these neurons in response to caloric reward (Figure 4H-K). 
 We subsequently ask if cell-type-specific manipulation of a gene that is 
differentially-expressed during obesity can attenuate the biological phenotype of HFD. 
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By generating a Cre-inducible virus expressing SaCas9 and a gRNA targeting the 
neuropeptide Nts, we show that cell-type-specific manipulation of neuropeptide 
signaling attenuates caloric intake, body fat composition, and weight gain under chronic 
HFD (Figure 9). Of note, Nts is expressed by only a small subpopulation of neurons in 
the LHA, suggesting that single-cell RNA-sequencing is an appropriate tool in identifying 
high-resolution functionally-relevant substrates for neurocircuit dissection. 
 Considering that LHAVglut2 activity directly modifies feeding and the survival of 
these neurons is essential in preventing weight gain during HFD exposure (Jennings et 
al., 2013; Stamatakis et al., 2016), we hypothesize that glutamatergic transmission from 
the LHAVglut2 functions as a brake on feeding behavior to suppresses food intake.  
Accordingly, we demonstrate that chronic HFD causes a robust allostatic shift in the 
transcriptional states of these neurons that ultimately dampens the activity of these 
neurons in response to caloric reward, thereby promoting continued motivated feeding 
and obesity. 
 Our findings in these experiments also suggest that LHA cell-state responses to 
HFD are dependent on inherent cell-type characteristics, even at high transcriptional 
resolution (Figure 7). Within neurons, these inherent characteristics may be dictated not 
only by the epigenomic and transcriptional features that typically define cell types, but 
also by their circuit level connectivity. Since neuronal populations are in rapid direct 
communication and exhibit neuroplastic changes in response to network-level events, 
the unique patterns of gene expression observed in LHA neuronal subtypes may be 
related to both inherent differences in cellular physiology and to perturbed proximal 
circuit-level activities that drive differential gene expression patterns within their distal 
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targets. Future studies should seek to dissect these pressures in a stereotyped 
neurocircuit model in which both connectivity and cell-type characteristics are more 
comprehensively understood 
 Unfortunately, our analysis of LHA transcriptional tuning during obesity did not 
explore neither the evolution of cell-states across the time course of weight gain on 
HFD, nor the temporal persistence of HFD-induced states after a return to standard 
chow. As such, these experiments cannot describe the kinetics of transcriptional 
allostatic trajectories in LHA feeding substrates during obesity. To investigate this idea 
more thoroughly, we studied the transcriptional effects of opiate dependence and 
withdrawal on cell-states in two brain regions that are known to be critical regulators of 
opiate dependence and withdrawal phenotypes (Figure 10). 
 The NAc is a critical integrator of rewarding and aversive signals from 
dopaminergic midbrain inputs. Within the NAc, these inputs synapse onto two 
populations of GABAergic medium spiny neurons expressing either the D1 (Drd1) or D2 
(Drd2) dopamine receptors. In general, Drd1-expressing medium spiny neurons project 
directly to output regions of the basal ganglia (direct pathway), whereas Drd2-
expressing medium spiny neurons in the NAc project indirectly to these output nuclei via 
the ventral pallidum (indirect pathway), although there are appreciable exceptions 
(Kupchik et al., 2015). Canonically, Drd1-expressing medium spiny neurons in the NAc 
encode rewarding experiences, while Drd2-expressing medium spiny neurons encode 
aversive signals (Hikida et al., 2010; Kravitz et al., 2012). However more contemporary 
work has recognized roles for both Drd1- and Drd2-expressing medium spiny neurons 
in communicating both positive and negative valence signals (Al-Hasani et al., 2015; 
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Soares-Cunha et al., 2019), suggesting functional—and possibly molecular—
heterogeneity within these cell-types. Consistently, both direct and indirect pathway 
neurons in the NAc have been shown to express a wide variety of both spatially-
restricted and intermixed neuropeptide and receptor systems (Castro and Berridge, 
2014; Castro and Bruchas, 2019). In support of this, we observed distinct 
transcriptionally-defined populations of both Drd1- and Drd2-expressing neuronal 
subtypes in the NAc (Figure 14A and C). 
 The MTC is comprised of multiple subnuclei (Figure 10C) including the 
intermediodorsal, mediodorsal, central medial, central lateral, and paraventricular 
nucleus of the thalamus (PVT) (Clascá et al., 2012; Jones, 2007). These regions have 
wide-ranging connectivity and are broadly involved in communicating information 
between cortical regions with sensory and subcortical systems. The MTC is broadly 
comprised of diverse array of primarily glutamatergic neuronal populations that can be 
distinguished by morphology, function, projection-specificity, and molecular composition 
(Clascá et al., 2012; Phillips et al., 2019). Consistently, we observe a number of 
spatially distinct distributions of cells within MTC neurons in UMAP space (Figure 12B), 
although these were not characterized in further detail. Within the MTC, the PVT 
displays robust connectivity with brain regions involved in reward seeking such as the 
prefrontal cortex, LHA, and NAc (Hsu, 2009; Otis et al., 2017, 2019; Ren et al., 2018), 
and plays a role in receiving and communicating both rewarding and aversive 
information (Browning et al., 2014; Choi and McNally, 2017; Otis et al., 2019; Penzo et 
al., 2015; Zhang and van den Pol, 2017). Accordingly, the PVT provides axon 
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projections to subcortical regions involved in reward and aversion, including the NAc 
(Dong and Swanson, 2004; Otis et al., 2019; Zhu et al., 2016).  
 Both the PVT and the NAc are involved in orchestrating reward and aversion 
during opiate dependence and withdrawal (Brunton and Charpak, 1998; Corre et al., 
2018; Hakan and Henriksen, 1989; Harris and Aston-Jones, 1994; Hearing et al., 2016; 
Koob, 1989; McDevitt and Graziane, 2019; Zhu et al., 2016). In mice, excitatory 
afferents from the PVT have been shown to communicate aversive signals to the medial 
shell of the NAc during naloxone-precipitated morphine withdrawal by acting on Drd2-
expressing medium spiny neurons (Zhu et al., 2016). Chronic morphine potentiates 
glutamatergic activity from the PVT to NAc indirect pathway neurons, and in vivo 
optogenetic inhibition of this projection during morphine withdrawal significantly reduces 
withdrawal-associated behaviors (Zhu et al., 2016). Together, these findings suggest 
that chronic opiate-induced changes in the functional characteristics of this projection 
population drives some of the negative features of withdrawal. Consistently, we observe 
robust changes in MTC neurons after chronic morphine administration (Figure 13B-D) 
and observe complex trajectories in both Drd1- and Drd2-expressing neurons in the 
NAc (Figure 13B-E). Of note, however, although we observe a high degree of 
transcriptional alteration in both NAc and MTC neuronal populations, those in the MTC 
appear to be more transient during withdrawal than in the NAc. 
 The opioid receptors comprise a class of seven-transmembrane domain 
inhibitory receptors (G protein-coupled receptors, GPCR) that includes four major 
subtypes, the most well characterized of which include the μ-opioid and κ-opioid 
receptors (Stevens, 2009). These receptors are widely distributed throughout the brain 
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and peripheral tissues. Endogenously, the μ-opioid receptor is the target of β-endorphin 
and enkephalins, whereas the κ-opioid receptor binds with high affinity to its 
endogenous ligand, dynorphin (Chavkin, 1982; Jordan, 2000). The μ-opioid receptor is 
the high-affinity prototypical receptor for drugs in the opiate and opioid classes, such as 
morphine (Koehl et al., 2018; Matthes, 1996). In general, the μ-opioid receptor is 
thought to relay hedonic or rewarding signals, whereas the κ-opioid receptor relays 
aversive experiences, and both receptors are distributed within the NAc and MTC 
(Brunton and Charpak, 1998; Castro and Berridge, 2014; Castro and Bruchas, 2019).  
 Canonically, ligand binding to the μ-opioid receptor activates its Gi alpha subunit, 
inhibiting adenylate cyclase and lowering cytosolic cyclic AMP (cAMP) concentrations. 
However, in the chronic state, activation of inhibitory GPCRs results in a paradoxical 
increase in cellular cAMP levels, termed superactivation (Avidor-Reiss et al., 1997; 
Sharma et al., 1975). This mechanism is thought to heavily contribute to both the 
development of tolerance and to withdrawal states following chronic opiate use (Avidor-
Reiss et al., 1995; Koob, 1996; Nestler, 1996; Self and Nestler, 1995). Within NAc 
medium spiny neurons, Drd1- and Drd2-dopamine receptor systems also influence 
cAMP levels through their actions as GPCRs, with Drd1 positively and Drd2 negatively 
regulating cytosolic cAMP levels (Lobo and Nestler, 2011). Within these neurons, cAMP 
acts as a messenger for widespread cellular events to coordinate changes in 
excitability, synaptic plasticity, and gene expression (Kandel, 2012). In vivo, acute and 
chronic morphine exposure has been shown to robustly modify cytosolic cAMP levels in 
the NAc, and these modifications are tuned by dopaminergic signaling (Muntean et al., 
2019). Thus, cAMP superactivation during dependence and withdrawal has the potential 
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to mechanistically direct transcriptional allostasis in NAc direct and indirect pathway 
neurons. 
 Considering this, our analysis identified the gene CAMP-Dependent Protein 
Kinase Inhibitor Beta (Pkib) as a robust marker of a subset of Drd1-expressing neurons 
in the NAc. Pkib belongs to a family of three highly-conserved genes which potently 
inhibit the ubiquitous cAMP-dependent Protein Kinase A (PKA) (Beale et al., 1977; 
Dalton and Dewey, 2006; Walsh et al., 1971). Although the expression of cAMP-
Dependent Protein Kinase Inhibitors genes in the brain has been broadly described 
(Seasholtz et al., 1995), their region- and cell-type-specific distribution and function 
within neuronal tissues remains uncharacterized. However, considering our finding that 
Pkib-expressing direct pathway neurons in the accumbens are robustly modified by 
chronic morphine and withdrawal (Figure 14C-F), as well as the role of dopaminergic 
and opioid receptor signaling on cytosolic cAMP in these neurons, we anticipate that 
Pkib may be a key regulator of transcriptional allostasis in Drd1-expressing medium 
spiny neurons in the NAc during opiate dependence and withdrawal. 
 In conclusion, this work presents a conceptual and analytical framework from 
which to consider how neuronal circuits are sculpted by allostatic pressures, and to 
identify both molecular features and cellular targets for further interrogation via 
conventional contemporary circuit dissection techniques. We believe that the theoretical 
perspectives and methodological approaches applied here can expand our ability to 
appreciate state-dependent functional dynamics in healthy and disrupted neurocircuit 
systems, both with higher specificity and at higher resolution. 
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